Slack, Graham

Slack, Graham

Slack, Graham

BSc, MD, FRCPC

Academic Rank(s): Clinical Associate Professor, Pathology and Laboratory Medicine, UBC | Oncologist, BC Cancer Agency | Director of Lymphoma Pathology, BC Cancer Agency

Affiliation(s): BC Cancer Agency

Research and Scholarly Interests: Cancer, Genetics genomics proteomics and related approaches

Clinical Interests:

gslack@bccancer.bc.ca

Short Bio
OpenClose

 

Academic
OpenClose

Academic Background

  • American Board of Pathology, Hematopathology. 2008
  • American Board of Pathology. Anatomic Pathology & Clinical Pathology. 2007
  • Fellow of the Royal College of Physicians of Canada. General Pathology.  2007
  • MD, University of British Columbia. 2002
  • BSc, (Hon) (Physiology), University of British Columbia. 1998

Awards and Recognition

Publications

Selected Publications

Research
OpenClose

Research Interest

  • Hematopathology
  • Hematological Malignancies
  • Lymphoma
  • Multiple Myelom

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

James, Gerald

Portrait photo of Gerald James

James, Gerald

MD

Academic Rank(s): Clinical Instructor, Pathology and Laboratory Medicine, UBC | Staff Pathologist, Royal Inland Hospital

Affiliation(s): Royal Inland Hospital

Research and Scholarly Interests: Blood research, Education

Clinical Interests:

gerry.james@interiorhealth.ca

Short Bio
OpenClose

Since 1998, I have worked as a general pathologist at Royal Inland Hospital in Kamloops, BC and have been very fortunate to practice all disciplines of laboratory medicine over the years. My practice now primarily focuses on hematopathology, including autoimmune testing, and medical biochemistry. For over eleven years, I served as both Department Head of Pathology and Laboratory Medicine at Royal Inland Hospital and also as the Area Medical Director of Thompson Cariboo Shuswap Labs in the Interior Health Laboratory System.

 

Academic
OpenClose

Academic Background

  • FRCP(C) General Pathology. 1998
  • American Board of Pathology Certification (Anatomical and Clinical Pathology). 1998
  • MD, University of British Columbia. 1992
  • BSc (Cell Biology), University of British Columbia. 1988

Awards and Recognition

  1. Interior Health Long Term Service Award – 20 years (2018)
  2. University of British Columbia, Faculty of Medicine, Department of Pathology and Laboratory Medicine Departmental Award 2022: Excellence in Clinical Service – Clinical Service in Other Settings (Community and Rural).

Publications

Selected Publications

  • G.K. James, K.W. Berean, A.G. Nagy, D.A. Owen. Inverted Meckel’s Diverticulum: an entity simulating an ileal polyp. The American Journal of Gastroenterology 93(9):1554-1555. Sep 1998
  • Gerald K. James, Doug Horsman, Joseph M. Connors, Richard Klasa, Ken Wilson,Larry Argatoff, Randy D. Gascoyne. Clinicopathological analysis of follicular lymphoma with a polyploid karyotype. Leukemia and Lymphoma: 28(3-4):383-9. Jan 1998
  • Gerald K. James, Michael W. Jones, Morris R. Pudek. Homocyst(e)ine levels in patients on phenytoin therapy. Clin Biochem. 1997 Dec;30(8):647-9.
  • Gerald K. James, Morris Pudek, Kenneth W.Berean, Eleftherios P. Diamandis, Betty Lou Archibald. Salivary duct carcinoma secreting prostate-specific antigen. American Journal of Clinical Pathology 106(2):242-247. 1996
  • Campbell M. Clark, Lili Kopala, Gerald James, Trevor Hurwitz and David Li. Metabolic subtypes in patients with schizophrenia. Biological Psychiatry 1993; 33:86-92.
  • Campbell M. Clark, Gerald James, David Li, Joel Oger, Donald Paty and Harry Klonoff. Ventricular size, cognitive function and depression in patients with multiple sclerosis. The Canadian Journal of Neurological Sciences 19:352-356. 1992
  • G.K. James, D.K. Kalousek and N. Auersperg. Karyotypic analysis of two related cervical carcinoma cell lines that contain human papillomavirus type 18 DNA and express divergent differentiation. Cancer Genetics and Cytogenetics 38:53-60. Mar 1989

Poster Presentations

  • Michelle Wong, Richard Cleve, Sonja Turnbull, Michael Nimmo, Sophia Wong, Carmen Phoon, Lorraine Romanin, Gerald James. A Multi-Site Inter-Regional Utilization Management and Quality Initiative for Autoimmune Testing. International Society of Laboratory Hematology (Vancouver, Canada, May 2019)
Research
OpenClose

Research Interest

Education

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

I teach UBC medical students and residents based at Royal Inland Hospital in the UBC Southern Medical Program. I also have a very keen interest in teaching medical laboratory technologists (MLT) and MLT practicum students from The British Columbia Institute of Technology and the College of New Caledonia.

Kalloger, Steve E

Kalloger, Steve E

BS, MSc, PhD

Academic Rank(s): Adjunct Professor, Pathology and Laboratory Medicine, UBC

Affiliation(s): Vancouver Coastal Health Pancreas Centre BCUBC Pathology and Laboratory MedicineUBC School of Population and Public HealthCanadian Centre for Applied Research in Cancer Control (ARCC)BC Cancer

Research and Scholarly Interests: Cancer, Genetics genomics proteomics and related approaches

Clinical Interests:

skalloger@mac.com

Short Bio
OpenClose

Over two decades experience in translational research with a focus in cancer and biomarkers to facilitate the goals of precision medicine. Also investigating the experience of patients in order to better understand how tumor agnostic therapies may be able to address the preferences of patients in the setting of metastatic disease

 

Academic
OpenClose

Academic Background

  • BS Biology – Humboldt State University, Arcata, CA U.S.A.
  • MSc Clinical Research – University of Liverpool, Liverpool, UK
  • PhD (Candidate) Population and Public Health, University of British Columbia, Canada

Awards and Recognition

  • Recipient of Excellence in Education Award from The UBC Department of Pathology and Laboratory Medicine (2019)

Publications

All peer reviewed publications are available at: https:// pubmed.ncbi.nlm.nih.gov/?term=kalloger&sort=date&ac=yes

Selected Publications

Research
OpenClose

Research Interest

Clinical Service

Current Projects In My Lab Include

  1. Current projects include – identification of predictive biomarkers in pancreatic and ampullary cancers, tumor heterogeneity and association with metabolic subtypes, and developing novel approaches for the integration of patient preference into formulary inclusion decisions.
Teaching
OpenClose

Teaching Interest

Lead Course Coordinator for PATH 535/635 , Co-coordinator for PATH 548L.

Palaty, Jan

Palaty, Jan

PhD, FCACB

Academic Rank(s): Clinical Instructor, Pathology and Laboratory Medicine, UBC

Affiliation(s): LifeLabs, Burnaby, BC

Research and Scholarly Interests: Urine drug testing, Substance use disorders, Bone metabolism, Clinical Biochemistry

Clinical Interests:

Jan.Palaty@lifelabs.com

Short Bio
OpenClose

Dr. Palaty obtained a PhD in Pharmaceutical Sciences from the University of BC in 1995.  He received his certification in Clinical Biochemistry from the Canadian Academy of Clinical Biochemists (CACB) in 2001.

Dr. Palaty has worked as a lab technologist at WorkSafe BC and clinical biochemist at BC Children’s Hospital.  He has worked at LifeLabs (or its subsidiary, the former BC Biomedical) since 2005, with a particular interest in clinical applications of mass spectrometry.

 

Academic
OpenClose

Academic Background

  • Canadian Academy of Clinical Biochemists Fellow. Jan 2001
  • PhD, University of British Columbia. 1995
  • MSc, University of British Columbia. 1990
  • BSc, University of British Columbia. 1987

Awards and Recognition

Publications

Selected Publications

  • Horvath GA, Davidson AG, Stockler-Ipsiroglu SG, Lillquist YP, Waters PJ, Olpin S, Andresen BS, Palaty J, Nelson J, Vallance H. Newborn screening for MCAD deficiency: experience of the first three years in British Columbia, Canada. Can J Public Health. 2008 Jul-Aug;99(4):276-80.
  • Copes R, Clark NA, Rideout K, Palaty J, Teschke K. Uptake of cadmium from Pacific oysters (Crassostrea gigas) in British Columbia oyster growers. Environ Res. 2008 Jun;107(2):160-9.
  • Leary SC, Cobine PA, Kaufman BA, Guercin GH, Mattman A, Palaty J, Lockitch G, Winge DR, Rustin P, Horvath R, Shoubridge EA. The human cytochrome c oxidase assembly factors SCO1 and SCO2 have regulatory roles in the maintenance of cellular copper homeostasis. Cell Metab. 2007 Jan;5(1):9-20. Erratum in: Cell Metab. 2007 May;5(5):403.
  • Innis SM, Palaty J, Vaghri Z, Lockitch G. Increased levels of mercury associated with high fish intakes among children from Vancouver, Canada. J Pediatr. 2006 Jun;148(6):759-63.
  • Nuttall KL, Palaty J, Lockitch G. Reference limits for copper and iron in liver biopsies. Ann Clin Lab Sci. 2003 Fall;33(4):443-50.
Research
OpenClose

Research Interest

  • Urine drug testing
  • Substance use disorders
  • Bone metabolism
  • Specialty: Clinical Biochemistry

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

  • Currently: Clinical mass spectrometry applications
  • Formerly: Clinical trace metals testing and newborn screening

Reyes, Romina

Reyes, Romina

BSc, MSc, MD (UBC)

Academic Rank(s): Clinical Associate Professor, Pathology and Laboratory Medicine, UBC | Medical Microbiologist, LifeLabs LP, Deputy Medical Director (BC)

Affiliation(s): LifeLabs, Surrey, BC

Research and Scholarly Interests: Infectious Diseases and Immunology Microbiology, Molecular Pathology and Cell Biology, Clinical Epidemiology, Statistical Analysis, Medical Microbiology

Clinical Interests:

romina.reyes@lifelabs.com

Short Bio
OpenClose

Dr. Romina Reyes, MSc, MD, FRCPC, Medical Microbiologist, is the Discipline Head of the Medical Microbiology department and Deputy Medical Director at LifeLabs Medical Laboratory Services. She is also a Clinical Assistant Professor with the UBC Faculty of Medicine Department of Pathology and Laboratory Medicine.

Romina has been actively involved in the UBC Medical School curriculum and teaching first year medical students in the Infectious Diseases/Medical Microbiology session. She is also involved in the teaching of the Medical Microbiology Residents at UBC.

Romina completed the Certificate Course in Laboratory Quality Management from the Faculty of Medicine, UBC during the end of her residency training and uses the practical knowledge from this course in the day to day management of the laboratory. She looks forward to actively participating in the course and facilitating active discussion and learning in the vital and exciting field of laboratory quality management.

 

Academic
OpenClose

Academic Background

  • MD, The University of British Columbia. 2004
  • MSc, The University of Western Ontario, Epidemiology & Biostatistics. 2000
  • BSc, The University of British Columbia, Microbiology. 1996

Professional Qualifications

  • Medical Microbiology FRCPC, The University of Western Ontario, London ON. 2009
  • University of BC Laboratory Quality Management certificate. Jun 2008
  • SHEA/CDC Training Certificate in Healthcare Epidemiology. Apr 2006
  • Transportation of Dangerous Goods (TDG) and IATA training certificate. Nov 2005

Awards and Recognition

Publications

Selected Publications

  • John MA, Burden J, Stuart JI, Reyes RC, Lannigan R, Milburn S, Diagre D, Wilson B, Hussain Z. Comparison of three phenotypic techniques for detection of methicillin resistance in Staphylococcus spp. reveals a species-dependent performance. J Antimicrob Chemother. 2009 Mar;63(3):493-6.
  • John MA, Burden J, Stuart JI, Reyes RC, Lannigan R, Milburn S, Diagre D, Wilson B, Hussain Z. Comparison of three phenotypic techniques for detection of methicillin resistance in Staphylococcus spp. reveals a species-dependent performance. J Antimicrob Chemother. 2009 Mar;63(3):493-6.
  • Reyes RC, Stoakes L, Milburn S, Lennox G, Daniel J, Silver SN, Wijnker E, John MA, Hussain Z. Evaluation of a new chromogenic medium for the detection of methicillin-resistant Staphylococcus aureus carriage on nasal and perianal specimens. Diagn Microbiol Infect Dis. 2008 Feb;60(2):225-7. Erratum in: Diagn Microbiol Infect Dis. 2008 Sep;62(1):116.
  • Chuo JY, Lee TY, Hollands H, Morris AH, Reyes RC, Rossiter JD, Meredith SP, Maberley DA. Risk factors for posterior vitreous detachment: a case-control study. Am J Ophthalmol. 2006 Dec;142(6):931-7.
  • Stoakes L, Reyes R, Daniel J, Lennox G, John MA, Lannigan R, Hussain Z. Prospective comparison of a new chromogenic medium, MRSASelect, to CHROMagar MRSA and mannitol-salt medium supplemented with oxacillin or cefoxitin for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2006 Feb;44(2):637-9.
  • Reyes RC, Hussain Z. Difficile-Associated Diarrhea: An Update on the Diagnosis and Management. Check Sample. 2005. Microbiology. Exercise 1. Vol 48. Abstract published in the American Journal of Clinical Pathology. 2006. Vol 125.
  • Thommasen HV, Klein MC, Mackenzie T, Lynch N, Reyes R, Grzybowski S. Obstetric maternal outcomes at Bella Coola General Hospital: 1940 to 2001. Can J Rural Med. 2005 Winter;10(1):13-21.
  • Young CS, Reyes RC, Beatty JT. Genetic complementation and kinetic analyses of Rhodobacter capsulatus ORF1696 mutants indicate that the ORF1696 protein enhances assembly of the light-harvesting I complex. J Bacteriol. 1998 Apr;180(7):1759-65.
Research
OpenClose

Research Interest

  • Clinical epidemiology and statistical analysis
  • Specialty: Medical Microbiology

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

Savard, Murray L

Savard, Murray L

MD, FRCPC (UBC)

Academic Rank(s): Clinical Instructor, Pathology and Laboratory Medicine, UBC | Medical Lab Director, Kelowna General Hospital

Affiliation(s): Kelowna General Hospital

Research and Scholarly Interests: Cancer, Infectious Diseases and Immunology Microbiology, Oncological Pathology

Clinical Interests:

dr.murray.savard@interiorhealth.ca

Short Bio
OpenClose

I grew up in Edmonton, graduated from the University of Alberta as a MD in 1981 and worked in the Canadian Armed Forces as a physician until returning to General Pathology at UBC. I graduated in 1991 with General Pathology certification and worked in Ottawa at National Defense Medical Centre as Chief of Laboratories, and was on staff at Queensway Carelton Hospital in Nepean, and was Laboratory Director of Gamma Dynacare Laboratory of Eastern Ontario until 1997. I then returned to Alberta where I worked for 9 years at David Thompson Regional Health Center in Red Deer. In Nov 2007 I began work at the Kelowna General Hospital.

 

Academic
OpenClose

Academic Background

  • FRCP(C) in General Pathology. 1991
  • MD, University of Alberta. 1981
  • BSc, University of Alberta. 1977

Awards and Recognition

  • Lecturer, University of Ottawa. 1995
  • NATO Decoration, Department of National Defence (DND).  1993
  • Canadian Decoration, DND. 1990
  • John James Owen Gold Medal in Pathology, University of Alberta. 1981

Publications

Selected Publications

Research
OpenClose

Research Interest

Infectious diseases, Oncological Pathology

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

Stefanovic, Aleksandra

Stefanovic, Aleksandra

MD, FRCPC

Academic Rank(s): Clinical Professor, Pathology and Laboratory Medicine, UBC | Medical Microbiologist, Providence Health

Affiliation(s): St Paul’s Hospital

Research and Scholarly Interests: Infectious Diseases and Immunology Microbiology

Clinical Interests:

astefanovic@providencehealth.bc.ca

Short Bio
OpenClose

Dr. Stefanovic completed her Medical Degree and internal medicine residency at University of Ottawa, followed by fellowships in infectious diseases and medical microbiology at the University of British Columbia. She works as a medical microbiologist at St. Paul’s Hospital in Vancouver.

She is Clinical Associate Professor and a Co-director of Infection Prevention and Control (IPAC) Educational Certificate Program, accredited by UBC. Along with her Co-directors, she is working on revamping the Certificate Program to make it more widely available to students interested in pursing a career in a dynamic field of infection prevention and control. Dr. Stefanovic is also actively involved in lecturing medical microbiology and infectious disease fellows, supervising and mentoring medical trainees at different stages of their medical education and training. She sits on the Educational Strategic Planning Committee for Department of Pathology and Laboratory Medicine, UBC.

Among her current research interests is studying the shift in Shigella spp. epidemiology, species dominance, pathogenicity and antibiotic resistance patterns in downtown Vancouver. Her team is also working on characterizing toxigenic Corynebacterium ulcerans, a zoonotic pathogen increasingly isolated from human wounds in downtown Vancouver.

 

Academic
OpenClose

Academic Background

  • University of British Columbia, Medical Microbiology Fellowship 2008-2010
  • University of British Columbia, Infectious Disease Fellowship 2006-2008
  • University of Ottawa, Internal Medicine Residency 2003 – 2006
  • University of Ottawa, MD 1998 – 2003
  • University of Alberta, BSc, Specialization in Chemistry 1994 – 1998

Awards and Recognition

Publications

PUBMED

Selected Publications

Research
OpenClose

Research Interest

  • Clinical impact of novel diagnostic/molecular testing
  • Laboratory utilization
  • Diagnosis of infections in transplant recipients

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

  • Course Instructor, Pathology 467
  • Lecturer, Pathology 722
  • Lecturer, UBC Infectious Diseases and Medical Microbiology Academic Half Day
  • Lecturer, FMED 401

Tomalty, Cheryl

Tomalty, Cheryl

BSc, PhD (Univ of Ottawa)

Academic Rank(s): Clinical Assistant Professor, Pathology and Laboratory Medicine, UBC

Affiliation(s): LifeLabs, Burnaby, BC

Research and Scholarly Interests: Clinical Applied Research, Routine Biochemistry, Immunoassay, Protein electrophoresis, Urinalysis, Fecal Immunochemical Testing, Clinical Biochemistry

Clinical Interests:

cheryl.tomalty@lifelabs.com

Short Bio
OpenClose

Dr. Tomalty graduated with a PhD in Biochemistry from the University of Ottawa and a post-doctoral Diploma in Clinical Biochemistry from the University of Toronto. She began her career as a Clinical Chemist at the North York General Hospital in 1981. She received her certification in Clinical Biochemistry from the Canadian Academy of Clinical Biochemists (CACB) in 1982.

Dr. Tomalty joined Dynacare Medical Labs (now Gamma-Dynacare) in Ottawa in 1985 as a Clinical Chemist, and was later appointed as Technical Director of Chemistry and Hematology. In 1994, she became the Laboratory Coordinator of the Montreal General Hospital responsible for administration of all the clinical laboratories, and she went on to lead the laboratory integration team of the three hospitals of the McGill University Health Centre. She then returned to Ottawa in 2000 as a Clinical Chemist with Abbott Point of Care, manufacturer of the i-STAT System, located in Ottawa.

Dr. Tomalty is a Founding fellow in the CABC and she was President of the Ontario Society of Clinical Chemists from 2005-2007. Dr. Tomalty joined LifeLabs in November 2007. She holds an appointment as Clinical Assistant Professor in the Dept. of Pathology and Laboratory Medicine at UBC.

 

Academic
OpenClose

Academic Background

  • Canadian Society of Clinical Chemists, Certification in Clinical Chemistry, 1982
  • Fellow of the Canadian Academy of Clinical Biochemists (CACB)
  • PhD, University of Ottawa. 1979
  • BSc, McGill University. 1974

Awards and Recognition

Publications

Selected Publications

Research
OpenClose

Research Interest

  • Routine Biochemistry
  • Immunoassay
  • Protein electrophoresis
  • Urinalysis
  • Fecal Immunochemical Testing
  • Cardiac Markers
  • Specialty: Clinical Biochemistry

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

Wong, Michelle

Wong, Michelle

BSc, MD

Academic Rank(s): Clinical Professor, UBC

Affiliation(s): Royal Columbian Hospital and Surrey Memorial Hospital, Fraser Health Authority

Research and Scholarly Interests:

Clinical Interests:

michelle.wong@fraserhealth.ca

Short Bio
OpenClose

Dr. Michelle Wong is originally from Calgary and subsequently moved to British Columbia to complete a B.Sc. in Biopsychology at UBC, her medical undergraduate degree at UBC and her postgraduate residency training in Hematological Pathology also at UBC. She has worked in Fraser Health since 2008 and enjoys a varied comprehensive clinical practice. She has served in numerous administrative roles including Division Head, Regional Medical Director for Hematopathology and is currently the Regional Medical Director for Transfusion Medicine. She is dedicated to and enjoys teaching medical students and residents sharing her love of Hematopathology! In her spare time, she enjoys reading, cooking, gardening and spending time with her friends and family.

 

Academic
OpenClose

Academic Background

  • Residency (Hematopathology), University of British Columbia. 2003 – 2008
  • MD, University of British Columbia. 2003
  • BSc (Psychology), University of British Columbia. 1998

Professional Qualifications

  • FRCPC Hematological Pathology
  • USMLE Step 3
  • LMCC Part II
  • USMLE Step 2
  • LMCC Part I
  • USMLE Step 1

Awards and Recognition

Publications

Selected Publications

Research
OpenClose

Research Interest

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

Actively involved in teaching medical students, interns, residents and fellows through electives and didactic teaching lectures

Wenzel, Dwayne

Wenzel, Dwayne

BSc, MD

Academic Rank(s): Clinical Instructor

Affiliation(s): Kelowna General Hospital

Research and Scholarly Interests: Blood research, Hematopathology, Transfusion medicine, General surgical pathology

Clinical Interests:

dr.dwayne.wenzel@interiorhealth.ca

Short Bio
OpenClose

 

Academic
OpenClose

Academic Background

  • FRCPC, General Pathology.  1998
  • MD, University of Alberta. 1993
  • BSc (Cell Biotechnology), University of Alberta. 1989

Awards and Recognition

Publications

Selected Publications

Research
OpenClose

Research Interest

  • Pathology – hematopathology
  • Transfusion medicine
  • General surgical pathology

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

Bradshaw, Barbra Allen

Bradshaw, Barbra Allen

BSc, MD, FRCPC

Academic Rank(s): Clinical Instructor, Pathology and Laboratory Medicine, UBC | Anatomical Pathologist, Abbostford Regional Hospital

Affiliation(s): Abbostford Regional Hospital

Research and Scholarly Interests: Endocrinology, Metabolism & Nutrition

Clinical Interests:

barbra.allenbradshaw@fraserhealth.ca

Short Bio
OpenClose

 

Academic
OpenClose

Academic Background

  • Fellow of the Royal College of Physicians of Canada – Anatomical Pathologist, May 2011
  • Doctor of Medicine, University of Alberta, 2005
  • BSc (Kinesiology), 1996

Awards and Recognition

Publications

Selected Publications

Research
OpenClose

Research Interest

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

I have developed an interest in Nutritional Health and Therapeutic Nutrition and give educational talks to members of the community, colleagues and fellow staff members at the hospitals I worked at, and work with the school community and school health professionals to increase the health of our school children by reducing sugar consumption in the schools.

Bradley, Amanda

Bradley, Amanda

PhD

Academic Rank(s): Associate Professor of Teaching, UBC

Affiliation(s): UBC Hospital

Research and Scholarly Interests: Scholarship of Teaching and Learning

Clinical Interests:

abradley@pathology.ubc.ca

Short Bio
OpenClose

I am an Associate Professor of Teaching dedicated to undergraduate education in the Bachelor of Medical Laboratory Science (BMLSc) Program. I was previously the Director of the BMLSc Program from 2013-2023. I have always found teaching to be very rewarding and am pleased to support students, BMLSc staff and fellow teachers, the Program, and our Department.

 

Academic
OpenClose

Academic Background

I have a BSc in Biochemistry and a PhD in Experimental Pathology. After several post docs, I became a research associate for the Canadian Blood Services. I enjoyed doing both foundational science research (with emphasis on the complement system, RBCs and platelets) and translational work (helping with the early stages of transition to the buffy coat method of preparing blood components). I have been a Faculty member in Pathology & Laboratory Medicine since 2002. In 2004, I joined the MD Undergraduate Program (MDUP) as a tenure-track Instructor. I was promoted to Senior Instructor in 2009. In 2013, I became the BMLSc Director and shifted my focus to the BMLSc Program. I obtained a Scholarship of Teaching and Learning Certificate on Curriculum and Pedagogy in Higher Education from the International Program for the Scholarship of Educational Leadership in 2016.

Awards and Recognition

  • Faculty of Medicine Distinguished Achievement in Education Award, 2023 and 2011
  • Killam Teaching Prize, 2018
  • Department of Pathology Award for Excellence in Education, 2022, 2010, and in 2005
  • BMLSc Graduates’ Choice Award for Teaching Excellence, 2022, 2019, and 2018
  • Philip Read Memorial Cup for Outstanding Contribution to the BMLSc Program, 2015

Publications

Selected Publications

Recent Conference Presentations:

  • A. Bradley, J. Li, A. Ho, A. Grieg. Student learning through student peer-assessment in a 4th year undergraduate course on research and career skills. International Society for the Scholarship of Teaching & Learning. 2022
  • A. Bradley, S. Bertolic, P. Wolfe A. Grieg. Student peer review and assessment – experiences from four diverse university disciplines. International Society for the Scholarship of Teaching & Learning. 2022
  • A. Bradley, A Ho and J Li. Student Peer Assessment to Improve Learning, Evaluation and Reflective Skills. CHES Celebration of Scholarship Research Presentation. Oct 7, 2020
  • A. Bradley. Transforming Your Course with Student Peer Assessment. 60-Minute Concurrent Session. LILLY-SAN DIEGO TEACHING FOR ACTIVE & ENGAGED LEARNING February 27-29, 2020
  • Greig A, Rankin A, Bradley A. Facilitating high quality clinical reflection writing in physiotherapy education – a calibrated peer-review process. World Confederation for Physical Therapy, 10-13 May. Geneva, Switzerland, 2019
  • Greig A, Rankin A, Bradley A. Peer Assessment and Feedback of Written Reflections in Physiotherapy Education. Paper accepted at the International Clinical Skills Conference (ICSC), 19-22 May; Prato, Italy, 2019
  • Greig A, Rankin A, Bradley A. Peer Assessment and Feedback of Written Reflections in Physiotherapy Education. Paper accepted at the Canadian Conference on Medical Education,April. Niagara Falls, Canada, 2019
  • Iqbal, I., Greig, A., Ho, A., Bradley, A., Rankin, A. Using student peer assessment to promote critical analysis skills and reflective abilities. CHES Celebration of Scholarship Research Presentation. Oct, 2016

Journal Research Articles:

  • A. J. Bradley, B.L. Read, E. Levin, D.V. Devine. Small-molecule complement inhibitors cannot prevent the development of the platelet storage lesion. Transfusion, 2008; 48:706-14.
  • A. J. Bradley and M.D. Scott. Immune complex binding by immunocamouflaged [Poly(ethylene glycol) -grafted] Erythrocytes. American Journal of Hematology, 2007; 82:970-975.
  • A. J. Bradley and M.D. Scott. Separation and purification of methoxypoly(ethylene glycol) grafted red blood cells via two-phase partitioning. J. Chromatography B, 2004; 163-168.
  • M. D. Scott, A.J. Bradley and K.L. Murad. Stealth Erythrocytes: effects of polymer grafting on biophysical, biological, and immunological parameters. Blood Transfusion, 2003; 1:245-266.
  • A. J. Bradley, K.L. Murad, K.L.Regan and M.D. Scott. Biophysical consequences
    of linker chemistry and polymer size on stealth erythrocytes: Size does matter. Biochim. Biophys. Acta. 2002, 1561:147-158.
  • A. J. Bradley, S.T. Test, K.L. Murad, J. Mitsuyoshi and M.D. Scott. Interactions of IgM ABO-antibodies and complement with methoxypoly (ethylene glycol)-modified human erythrocytes. Transfusion, 2001; 41:1225-1233.
  • M. D. Scott, A.J. Bradley, and K.L. Murad. Camouflaged blood cells: low technology bioengineering for transfusion medicine? Transfusion Med. Rev., 2000; 14:53-63.
  • A. J. Bradley, E. Maurer-Spurej, D.E. Brooks and D.V. Devine. Unusual electrostatic effects on binding of C1q to anionic liposomes: role of anionic phospholipid domains and their line tension. Biochemistry, 1999; 38:8112-8123.
  • D. V. Devine, A.J. Bradley, E. Maurer, E. Levin, S. Chahal, K. Serrano and M.I.C. Gyongyossy-Issa. Effects of prestorage leukoreduction on platelet aggregate formation and the activation state of platelets and plasma enzyme systems. Transfusion, 1999; 39:724-734.
  • A. J. Bradley, D.E. Brooks, R. Norris-Jones and D.V. Devine. C1q binding to liposomes is surface charge dependent and is inhibited by peptides consisting of residues 14-26 of the human C1qA chain in a sequence independent manner. Biochem. Biophys. Acta, 1999; 1418:19-30.
Research
OpenClose

Research Interest

My focus is on teaching and learning. I have been studying the outcomes of incorporating student peer assessment into a 4th year course, the Research and Career Skills course. My interest in student peer assessment has led to various collaborations and at looking at the impact of student peer assessment in broader settings.

I have also been involved in evaluating an Academics Without Borders-funded Program in East Africa called Africa MicroResearch.  The Program version I evaluated was for Medical residents at Kabarak University in Kenya (2019/20, during my sabbatical).

My foundational science expertise is in the areas of immunology (particularly Complement), biochemistry and hematology.

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

My primary commitment is to the Bachelor of Medical Laboratory Science program. As Associate Professor of Teaching, I coordinate and teach in a variety of courses; I have redeveloped several courses, striving to use more effective pedagogies; I contribute to innovative educational practices, support my colleagues and disseminate best practices; I champion the continual improvement and renewal of courses and the Program overall.

I am currently Course Coordinator and teach in the following BMLSc courses: Pathology 300 (Clinical Chemistry section), Pathology 405 (Seminars in Current Topics), and Pathology 408 (Research and Career Skills). I have previously taught and been course coordinator for Pathology 415 (Immunopathology) and, before that, for Pathology 402 (Hematopathology).

From 2016-2019, along with collaborators in the Physical Therapy program, I held a Teaching and Learning Enhancement Fund grant to incorporate student peer-review into the curriculum. Over the course of the 3 years of the grant, we re-developed the PATH 408 – Research and Career Skills course to include 2 student peer-review assignments. Outcome measures show enhanced student learning (improved quality of assignments), perception of learning, attitudes about peer review, and abilities to provide helpful feedback.

Past curriculum development experiences include: developing Program level learning outcomes, leading BMLSc curriculum improvement cycles, incorporating evidence-based practice into Problem based learning cases, implementing and evaluating a lecture recording pilot (which led to a policy change on lecture recording in the MD Program), creating on-line modules for student self-study of Immunology, and writing a new PBL case. I was previously an active member of three MD Program curriculum renewal committees.

My Teaching Philosophy:

Effective teaching requires a student-centered approach that focuses on opportunities for students to build on their prior knowledge and experiences. Active involvement of students with the material, with the instructor and with each other is crucial. Through discussion and learning activities, students elaborate on what they know and push the boundaries of their knowledge, creating an intrinsic motivation to learn more.

I strive to provide students with an educational experience that is congruent with my beliefs about teaching and learning. To do so, I design and add-lib a variety of learning activities that promote student involvement, and I encourage students to take ownership and responsibility for their own learning. Most importantly, I see my role as helping students to learn.

Monsalve, Maria Victoria

Monsalve, Maria Victoria

BSc, MSc, PhD, Univ of Sao Paulo, Brazil

Academic Rank(s): Associate Professor of Teaching, Undergraduate Medical Education Program, Pathology and Laboratory Medicine, UBC

Affiliation(s): BC Cancer Research Centre

Research and Scholarly Interests: Genetics genomics proteomics and related approaches, Molecular Pathology and Cell Biology, Genetic in Cardiovascular Diseases, Paleopathology, Forensic DNA

Clinical Interests:

vmonsalve@pathology.ubc.ca

Short Bio
OpenClose

Presently teaching to MD undergraduate and BMLSc students.

I have developed the activity “Hands on Archaeological and Historical Medical collection as a FLEX activity for MD students in 2nd and 4th year.

One of my interests is to better understand and diagnose today’s diseases through the application of interdisciplinary knowledge ofpathologies observed in ancient human remains. During three separate visits to the UK and in collaboration with the University of Bournemouth, the British Museum (UK) and the National University (Colombia), I accessed skeletons and bones presenting varied pathologies. Photographs of these collections are available for students studying disease through human remains. UBC’s FLEX (Flexible Enhancing Learning) has given me an opportunity to contribute my knowledge and experience to educational activities in paleomedicine for undergraduate medical students. Second and 4th year MD undergraduate students have been engaged since 2018. Recently, I supervised a first year MD undergraduate student through the course “steoarchaeology: The Truth in Our Bones” offered by the University of Leiden (Holland). A student of the Department of Biochemistry and Molecular Biology informally attended presentations for FLEX activities by my students for one year.

Teaching Path 406 to BMLSc students (two hour lecture on DNA Systems)

 

Academic
OpenClose

Academic Background

  • Postdoctoral Training: University of Cambridge (UK)
  • PhD, Biology (Genetics), University of Sao Paulo, Brazil
  • MSc, Biology (Genetics), University of Sao Paulo, Brazil
  • BSc, Biology, University of the Andes, Colombia

Awards and Recognition

Publications

Selected Publications

  • Aaron J. Moulson AJ , Monsalve MV Case-based paleomedicine as an educational tool for pre-clinical medical students. Paleopathology Newsletter 2021.
  • Monsalve MV, Humphrey E, Walker DC, Nimmo M, Zhao J, Cheung C, Hazelton P. (2017). Analysis of microorganisms in bone and muscle tissues in the Kwaday Dan Ts’inchi find. Kwaday Dan Ts’inchi: Teaching from Long Ago Person Found. Ed. Richard J. Hebbda, Sheila Greer & Alexande P. Mackie. pg 223-231.
  • Monsalve MV. (2017). Origins of the Kwaday Dan Ts’inchi. Kwaday Dan Ts’inchi: Teaching from Long Ago Person Found. Ed. Richard J. Hebbda, Sheila Greer & Alexander P. Mackie. pg 249-255.
  • Monsalve MV, Humphrey E, Vogl W, Nimmo M, Zhao J, Cheung C, Walker DC. (2017). The Use of Cellular Structure in Ancient Frozen human Remains To Predict DNA Retrival. Kwaday Dan Ts’inchi. Teaching from Long Ago Person Found. Ed. Richard J. Hebbda, Sheila Greer & Alexander P. Mackie Pg 265-276.
  • Monsalve MV, Humphrey E, Walker DC, Cheung C, Swanston T, Deneer H, Hazelton P, Oda G, Kahila E, Bar-Gal G, Spigelman M. (2017). “Report of a Multidisciplinary Workup of the Kwaday Dan Ts’inchi Human Remains from Canada: Microorganisms Analyses.” In Mummy and Science. World Mummies Research, edited by Peňa P. A, Martin CR, Rodrigez AR. Santa Cruz de Tenerife Academis Canaria de La Historia.
  • Quaroni L, Christensen CR, Chen B, Vogl W, Monsalve MV. (2013). Detection of protein structure of frozen remains recovered from a glacier in Canada using synchrotron-Fourier Transform Infrared (FTIR) Spectromicroscopy. Microsc. Microanal. 19:565-575.
  • Liu C, Park H-M, Monsalve MV, Chen DDY. (2010) Qualification of free fatty acids in adipocere of the Kwaday Dän Ts’inchi ancient remains found in glacier in Canada. J Forensic Sci 55: 1039-1043.
  • Monsalve MV, Humphrey E, Walker DC, Cheung C, Vogl W, Nimmo M. Brief communication: state of preservation of tissues from ancient human remains found in a glacier in Canada. Am J Phys Anthropol. 2008 Nov;137(3):348-55.
  • Monsalve MV, Stone AC. (2005) “mtDNA Linage Analysis: Genetic Affinities of the Kwaday Dan Ts’inchi Remains with Other Native Americans.” In Biomolecular Archaeology: Genetic Approaches to the Past, edited by DM Reed, 9-21. Occasional Paper No.2 (2). Carbondale: Southern Illinois University Press.
  • Monsalve MV, Thommasen HV, Pachev G, Frohlich J. (2005) Difference in cardiovascular risks in the aboriginal and non-aboriginal people living in Bella Coola, British Columbia. Medical Science Monitor. 11: CR 21-28. 2004
  • Monsalve MV. (2004). HLA-DRB1 allele frequencies in a Penutian Population from BC, Canada. Human Immunol. 65 (9-10): 898-899 Sp. Iss. SI.
  • Monsalve MV. (2004). HLA-DQA1-DQB1 and DRB1 allele frequencies in an Athabaskan population from BC, Canada. Human Immunol. 65 (9-1): 899-900 Sp. Iss. SI.
  • Rupert JL, Monsalve MV, Kidd KK, Tan C, Hochachka PW, Devine DV. (2003). Selective pressure has not acted against hypercoagulability alleles in high-altitude Amerindians. Ann. Hum. Genet. 67:426-432.
  • Rupert JL, Kidd K, Norman LE, Monsalve MV, Hochachka PW, Devine DV. (2003). Genetic polymorphisms in the renin-angiotensin system in high-altitude and low-altitude Native American populations. Ann. Hum. Genet. 67:17-25.
  • Monsalve MV, Salzano FM, Rupert J, Hutz MM, Hill K, Hurtado AM, Devine DV. (2003). Methylenetetra hydrofolate Reductase (MTHFR) allele distribution frequency Amerindians. Ann. Hum. Genet. 67:367-371.
Research
OpenClose

Research Interest

  • Genetic in cardiovascular diseases
  • Paleopathology
  • Forensic DNA

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

Tutoring in Problem Based Learning, Case Based Learning , Supervising in FLEX, teaching in Pathology 406.

Huynh, Hanh

Huynh, Hanh

Interdisciplinary PhD

Academic Rank(s): Associate Professor of Teaching, Pathology and Laboratory Medicine, UBC | Vancouver Fraser Medical Program Year 1 Site Director

Affiliation(s): Life Sciences Centre

Research and Scholarly Interests: Cancer, Endocrinology, Metabolism & Nutrition, Scholarship of Teaching of Education Research

Clinical Interests:

hanh.huynh@ubc.ca

Short Bio
OpenClose

Born and raised in Saigon, Vietnam, Dr. Huynh came to Canada in 1980 as a political refugee. After working for 2 years in Trail at Cominco, he started his first year of Sciences at Selkirk College. In 1994 he graduated from UBC with an Interdisciplinary Ph.D. in Neuroscience and Experimental Pathology.

After completing a one-year Post-Doctoral Fellowship at Rockefeller University in New York, he was promoted to Assistant Professor in the Department of Neurology at Nebraska Medical University. In 1996 he moved back to Vietnam to be with his wife who was not allowed to leave the country, as she was one of the only two female Urologists in southern Vietnam. For the next 6 years, Dr. Huynh worked for a British humanitarian organization trying to prevent exploitation of street children and for a French pharmaceutical company, Les Laboratoires Servier, as Training Manager. During the 5 year tenure with Servier, Dr. Huynh used small group teaching (called “Coaching” – similar to Problem Based Learning {PBL} tutoring) to train medical representatives and junior colleagues in the company.

In 2002, he returned to Canada with his wife Lien Vo and their two children and assisted UBC with its M.D. Undergraduate Program, tutoring PBL to medical & dental students and assisting Faculty Development with training of new PBL tutors for the program. In 2004, Dr. Huynh was appointed Director, Foundations of Medicine, Northern Medical Program (NMP) at the University of Northern British Columbia, BC, Canada. In addition to the administrative duties, Dr. Huynh continued to train new PBL tutors for the NMP until the summer of 2007 when he resigned this post to move back to Vancouver. Since rejoining the Vancouver Fraser Medical Program, Faculty of Medicine, UBC, as an Instructor, Dr. Huynh continues with his PBL tutoring and training new PBL tutors for the Medical Undergraduate Program.

His current academic and professional interest is in the field of immunometabolism, the application of evidence based principles in the prevention of Non Communicable Diseases such as Obesity, Diabetes and Cancer.

 

Academic
OpenClose

Academic Background

  • Histology
  • Immunology
  • University of British Columbia, Interdisciplinary PhD, Neurosciences & Exp. Pathology, 1989-1994
  • University of British Columbia, M.Sc., Cell Biology, 1986-1989
  • University of British Columbia, B.Sc., Cell Biology, 1983-1986

Awards and Recognition

Awards for Teaching

  • Nomimated for the “Faculty of Medicine Distinguished Achievement Award for Excellence in Education” May 2012
  • 2010/06, Tips for Teaching in the UBC Distributed Medical Education Program, The award and certificate were presented at the Medical Education Days for Health Professionals, hosted by the Office of Faculty Development, Medicine, UBC

Awards for Scholarship

  • Student Summer Internship Program, The University of British Columbia, ($4,800 for the summer of 2009) Co-supervise with Dr. Amanda Bradley 2 medical students to develop the Basic Immunology Learning Module,June & July 2009.

Awards for Service

  • Tea and Cookies Award, The award was presented at the Curriculum Annual Retreat by the Office of Student Affairs (Drs. Sharon Salloum & Barb Fitzerald – Associate & Assistant Dean respectively – Student Affairs), Medicine, UBC,June 24, 2010, to recognize the contribution to Student Support and Development.

Publications

Selected Publications

  • Management of child obesity: School – Community – Family Approach. Journal of Food and Nutritional Sciences, July 2014, Vol 10 (2): 107 – 111.
  • Pathophysiology & Evidence-Based Prevention Principles for Non Communicable diseases. Journal of Food and Nutrition Sciences, August 2013, Vol 9 (3): 9 – 15.
  • “Twelve tips for teaching in a provincially distributed medical education program” Medical Teacher 2012; Volume 34: 116 – 122
  • Kelly N, Gaul K, Huynh H, Linn Grunau G, Murphy C. Quality trumps face-to-face presence when delivering lectures in a distributed multi-site education programme.Medical education 2008 42 (2): 225.
  • Liao F,Huynh H, Eiroa A, Greene T, Polizzi E. and Muller W. Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1.J. Exp. Med.Vol 182: 1337 – 1343, 1995.
  • Huynh H, Oger J, and Dorovini-Zis K. Interferon beta downregulates interferon gamma-induced class II MHC molecule expression and morphological changes in primary cultures of human brain microvessel endothelial cells.J. Neuroimmunol.Vol 60: 63 – 73, 1995.
  • Huynh H. and Dorovini-Zis K. Effects of Interferon gamma on primary cultures of human brain microvessel endothlelial cells.Am. J. Path.Vol 142(4): 1265 – 1278.
  • Dorovini-Zis K. andHuynh H. Ultrastructural Localization of Factor VIII-related antigen in cultured human brain microvessel endothelial cells.J. Hist. Cytochem.Vol 40(5): 689 – 696, 1992.
  • Oliveria L. andHuynh H. Phototrophic growth of microalgae with allantoic acid or hypoxanthine serving as nitrogen source, implications for purine Nitrogen utilization.Can. J. Fish. & Aquatic Sciences47(2): 351 – 356, 1990.
  • Oliveria L. andHuynh H. Ultrastructure and cytochemistry of Dunaliella tertiolecta Butcher and Pavlova lutheri (Droop) Green grown on three different sources of organic nitrogen.New Phytology113: 481 – 490, 1989.
  • Oliveria L. andHuynh H. Ultrastructure and cytochemistry of the marine dinoflagellate Amphidinium carterae grown on three sources of nitrogen. J. Submicrosc. Cytol. Pathol.21(4): 641 – 651, 1989.
  • Oliveria L. andHuynh H, Burns A, Mackenzie A. The utilization of Bovine Serum Albumin in the preparation of unicellular organisms for cytological studies.Cytologia54: 325 – 333, 1989.

(b) Conference Proceedings

  • Prevalence of Overweight and Obesity in children in Prince George, BC Canada. Childhood and Adolescent Obesity 2006 Oct 5 – 7 2006 Vancouver BC.
  • Prevention of Type 2 Diabetes in Children – 7th National Canadian Rural & Remote Health Conference Oct 19 – 21 2006 Prince George BC.
  • Social Determinants and Childhood Obesity in School District 57 Prince George British Columbia, Canada. Canadian Association for Physical Anthropology Meeting – Peterborough, Ontario, Canada Oct 25 – 28, 2006.
  • Social Determinants of Childhood Overweight and Obesity in elementary School children from Prince George, BC, Canada. Human Biology Conference Mar 28-29 2007 Philadelphia PA USA.
  • Obesity in children & Its consequences : Congress Abstract 19th VIETNAM CONGRESS OF PEDIATRICS – For Millennium Goal of Vietnamese Child Health Ho Chi Minh City Dec 27 & 28, 2008; 62 – 67.

(c) Other

  • Quality trumps face-to-face presence when delivering lectures in a distributed multi-site medical education program. Niamh Kelly, Kathy Gaul, Hanh Huynh, Gilat Linn Grunau & Caroline Murphy. MEDICAL EDUCATION 2008, Volume 42: 225.

2. NON-REFEREED PUBLICATIONS

  • K.L. Schmidt, Lau H., Huynh H., White V., Taylor T., Dorovini-Zis K. Neuropathology of cerebral malaria. Can. J. Neurol. Sci. 29(4): 396, November 2002.
  • Huynh H. and Dorovini-Zis K. Effects of Interferon gamma and beta on the adhesion and migration of lymphocytes across human brain endothelial cells in vitro. Can. J. Neurol. Sci. 20 (Suppl. 4): S104, 1993.
  • Huynh H. and Dorovini-Zis K. Adhesion and migration of T lymphocytes across human brain endothelial cell monolayers: role of Interferon gamma. J. Neuropath. & Exp. Neurol. 52(3): 316, 1993.
  • Huynh H. and Dorovini-Zis K. Downregulation of interferon gamma induced functional and morphological changes on human brain microvessel endothelial cells by recombinant human interferon beta. J. Neuropath. & Exp. Neurol. 51(3): 378, 1992.
  • Dorovini-Zis K and Huynh H. Ultrastructural Localization of Factor VIII/von Willebrand antigen in cultured human brain microvessel endothelial cells. J. Neuropath. & Exp. Neurol. 50(3): 345, 1991.
  • Huynh H. and Dorovini-Zis K. Induction of Ia antigen expression on human brain microvessel endothelial cells by interferon gamma in vitro. J. Neuropath. & Exp. Neurol. 50(3): 354, 1991.
Research
OpenClose

Research Interest

The overall foundation for my professional interest in these categories are Immunology.

  • Immunometabolism
  • Prevention of Chronic Diseases (Obesity, Diabetes, Cancer)

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

Crawford, Richard

Crawford, Richard

Academic Rank(s): Clinical Professor, Pathology and Laboratory Medicine, UBC

Affiliation(s): Anatomic Pathology and Dermatology, VGH

Research and Scholarly Interests: Infectious Diseases and Immunology Microbiology, Skin Conditions

Clinical Interests:

richaric@mail.ubc.ca

Short Bio
OpenClose

Double board-certified in both Anatomic Pathology and Dermatology, Dr. Richard Crawford is a leading expert in dermatopathology.

 

Academic
OpenClose

Academic Background

  • MD, University of British Columbia.  1987

 

SPECIAL PROFESSIONAL QUALIFICATIONS

  • Diploma, Physicians’ Executive Management Program, Simon Fraser University, 2003
  • Diploma, Dermatopathology, American Boards of Dermatology and Pathology, 1997
  • Diploma, Dermatology, American Board of Dermatology, 1997
  • Certificate, Dermatology, Royal College of Physicians and Surgeons of Canada, 1997
  • Certificate, Anatomical Pathology, Royal College of Physicians and Surgeons of Canada,1993
  • Diploma, Anatomic and Clinical Pathology, American Board of Pathology, 1992
  • Certificate, General Pathology, Royal College of Physicians and Surgeons of Canada, 1992
  • Certificate of Registration, Medical Council of Canada, 1988

Awards and Recognition

Publications

Selected Publications

Research
OpenClose

Research Interest

Skin Conditions

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

Verchere, Bruce

Verchere, Bruce

BSc, MSc, PhD (Brit. Col.)

Academic Rank(s): Professor, Pathology and Laboratory Medicine, UBC

Affiliation(s): BCCH/BCCHRI

Research and Scholarly Interests: Endocrinology, Metabolism & Nutrition, Infectious Diseases and Immunology Microbiology, Professional Contributions

Clinical Interests:

verchere@mail.ubc.ca

Short Bio
OpenClose

Dr. Bruce Verchere is a professor in the departments of surgery and pathology & laboratory medicine at the University of British Columbia (UBC), and head of the Diabetes Research Program at the Child & Family Research Institute.

He is also the chair of the National Research Council at the Canadian Diabetes Association, and chair of the Canadian Institutes of Health Research’s Diabetes, Obesity and Lipids grant review panel. Verchere’s research focuses on understanding how pancreatic beta cells normally function, and why they are dysfunctional and die in type 1 and type 2 diabetes and following islet transplantation. He holds the Irving K Barber Chair in Diabetes Research at UBC, and is a recipient of MSFHR’s 2006 Senior Scholar

 

Academic
OpenClose

Academic Background

  • Post-doctoral fellow (Molecular Biology), University of Geneva, Geneva, Switzerland. 1997
  • Post-doctoral fellow (Medicine), Veterans Affairs Medical Center, Seattle, Washington Department of Medicine, Seattle, WA. 1996
  • PhD, University of British Columbia, Physiology. 1991
  • MSc, University of British Columbia, Physiology. 1987
  • BSc, University of British Columbia, Cell Biology. 1983

Awards and Recognition

Publications

For a list of Dr. Verchere’s publications, click here

Selected Publications

Research
OpenClose

Research Interest

  • Type 1 diabetes and type 2 diabetes
  • Beta cell biology, islet amyloid, amylin, insulin, prohormone processing, apoptosis, hormone secretion, transgenic mice, islet transplantation, autoantigens, histology

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

Minchinton, Andrew

Minchinton, Andrew

BSc (Hons), PhD

Academic Rank(s): Associate Professor, Distinguished Scientist, Pathology and Laboratory Medicine, UBC

Affiliation(s): BCCA/BCCRC

Research and Scholarly Interests: Biomaterials, Cancer, Clinical Applied Research

Clinical Interests:

aim@bccrc.ca

Short Bio
OpenClose

Andrew Minchinton obtained a PhD in Radiation Biology at University College London & Gray Laboratory. After a post-doctoral fellowship in Vancouver he was recruited by J. Martin Brown to work as a staff scientist in the Cancer Biology Research Laboratory at Stanford University.

After 3 years in California, and bored with life in Palo Alto, he was recruited back to Vancouver and is now a Distinguished Scientist in the Department of Integrative Oncology and Head of the Radiation Biology Unit at BC Cancer. He is an Associate Professor in Pathology and Laboratory Medicine and also teaches a Radiation Biophysics course in the Department of Physics and Astronomy at UBC.

Major interests include how the tumour microenvironment influences radiotherapy outcome with particular interest in oxygen and the electron transport chain, extravascular drug distribution, DNA damage repair and drug discovery. Most recently, focus has been on translational developments to discover a cancer targeted inhibitor of a pivotal DNA repair protein as well as fundamental experiments on FLASH radiotherapy

Dr. Minchinton has received over $20M in peer-reviewed operating grants, has published over 100 peer-reviewed articles (which have been cited over 6000 times). He has 6 patents including a library of over 1000 new chemical entities related to DNA-PK inhibitors and currently holds three CIHR operating grants and a Pancreas Centre BC IDEAS grant. His recent accolades include the Robert F. Kallman award for academic leadership, scientific excellence, service to the profession and commitment to colleagues, students and Stanford University.

 

Academic
OpenClose

Academic Background

  • Medical Biophysics Unit, BC Cancer Research Centre. Post-doctoral Fellow. 1989
  • University of London, Middlesex Hospital Medical School & CRC Gray Laboratory, Northwood, UK. PhD (Radiation Biology). 1986
  • University of Hertfordshire, United Kingdom. BSc (Biochemistry Hons, Biochemistry). 1978

Awards and Recognition

Publications

Dr. Andrew Minchinton | Google Scholar

Research
OpenClose

Research Interest

Minchinton Lab

Dr. Andrew Minchinton Laboratory is working to address multiple key topics in cancer research. One such area is how the tumour microenvironment can influence the effectiveness of treatments like radiation and chemotherapy. The tumour microenvironment refers to the area occupied by a given collection of tumour cells and all its surrounding cells, vessels, and supporting structures. This microenvironment can have a significant impact not only on how rapidly a tumour can grow and whether it can spread to other parts of the body, but also on whether a given treatment will be effective. For example, the relative amount and arrangement of blood vessels associated with a tumour can affect how chemotherapy targeting that tumour is delivered – and how effective it will ultimately be in killing cancer cells. Dr. Minchinton’s group has developed tools to analyze how effective this delivery is for different drugs in different cancer types.

“Hypoxia” refers generally to a lack of oxygen and can be observed in tumours that are growing so quickly that they are exhausting their oxygen supply. Interestingly, tumour cells that are hypoxic can have relatively lower responsiveness to chemotherapy or radiation. Dr. Minchinton’s group has developed ways to measure tumour oxygen levels and is devising new drugs that can be applied to work against tumour hypoxia and thus increase the effectiveness of radiation and chemotherapy treatments.

To address the above cancer research topics, Dr. Minchinton’s team also developed new models of the tumour microenvironment that can be evaluated in a lab setting. These models are three dimensional in nature and can be used to measure changes in the concentration of cellular oxygen or anticancer drugs (thus determining how effectively a given drug is distributed across an entire collection of tumour cells).

The combination of these tools and expertise make the Minchinton lab world leaders in the field of radiation biology research.

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

  • Radiation biology is a rarely taught discipline with enormous socioeconomic importance. Public understanding of the nature of ionizing radiation, its uses in medicine and its dangers to the public are woefully inadequate and result in media misrepresentation and public skepticism to official announcements when radiation related accidents occur. Through my lectures I attempt to provide a balanced picture of the importance of ionizing radiation to society and via a basic understanding of the effects of ionizing radiation on DNA, cells and tissues provide students with the tools to interpret radiation risk and the beneficial effects such as diagnostic tools and cancer treatment.
  • Radiation biology is a rarely taught discipline with enormous socioeconomic importance. Public understanding of the nature of ionizing radiation, its uses in medicine and its dangers to the public are woefully inadequate and result in media misrepresentation and public skepticism to official announcements when radiation related accidents occur. Through my lectures I attempt to provide a balanced picture of the importance of ionizing radiation to society and via a basic understanding of the effects of ionizing radiation on DNA, cells and tissues provide students with the tools to interpret radiation risk and the beneficial effects such as diagnostic tools and cancer treatment.

Sadar, Marianne D

Sadar, Marianne D

BSc, PhD

Academic Rank(s): Professor, Distinguished Scientist, Pathology and Laboratory Medicine, UBC

Affiliation(s): BC Cancer Agency

Research and Scholarly Interests: Cancer, Genetics genomics proteomics and related approaches, Professional Contributions

Clinical Interests:

msadar@bcgsc.ca

Short Bio
OpenClose

Sadar Lab. We are located at Canada’s Michael Smith Genome Sciences Centre, part of the BC Cancer Research Centre.

Dr. Sadar has served in leadership roles internationally and was the first Canadian to serve as Chair of the USA Army’s Department of Defence’s Programmatic Panel for Prostate Cancer Research. She was President of the Society of Basic Urologic Research (USA) and a board member of education, research, and scientific advisory committees and boards for American and Canadian non-profit societies. Of note, Dr. Sadar was appointed to the Board of Trustees for Canada’s National Museum of Science and Technology by the Minister of Heritage. She has served on over 50 grant panels including five years on the NIH study session for Drug Discovery & Molecular Pharmacology. Her research has gained considerable media attention over the years with many interviews on radio, newspapers, television, and on the internet. Her research has also received awards such as an Honorary Doctorate (Doctor of Letters, honoris causa), the USA SWIU/SBUR Award for Excellence in Urologic Research, Simon Fraser University’s Outstanding Alumni Award for Academic Achievements, and the Terry Fox Young Investigator Award. Dr. Sadar is an expert witness for Astellas, Pfizer, and University of California on patents covering Xtandi®, used for the treatment of prostate cancer in the USA with global sales greater than $3.5 billion per year.

 

Academic
OpenClose

Academic Background

  • PhD, Biochemistry, University of Bradford, UK / University of Göteborg, Sweden. 1995
  • BSc, Biochemistry, Simon Fraser University. 1988

Awards and Recognition

Publications

Selected Publications

Research
OpenClose

Research Interest

  • Prostate cancer
  • Drug Development
  • Transcriptional regulation

Dr. Sadar’s research accomplishments and experience over 22 years is essentially entirely focused on the development of therapeutics for prostate cancer. In 1999, Dr. Sadar discovered a novel drug target for prostate cancer. She then partnered with a chemist, Dr. Andersen, to screen drugs against this target, and discovered a clinical candidate of this drug. Dr. Sadar Founded a biotech company in 2009, called ESSA Pharma Inc, to develop the drug for testing in clinical trials. This was successful and First-in-human clinical trials completed at 4 sites in USA and 1 site in Canada Clinical/Trials.gov Identifier: NCT02606123. Only one in a thousand drugs that show promise in laboratory studies and animal models ever reaches human testing. Dr. Sadar’s drug is the first drug in clinical trials that directly binds to an intrinsically disordered protein region and a first in class drug to the N-terminus of the androgen receptor. The work is precedent in the entire field of steroid hormone receptors, with no other small molecule inhibitor reported to bind to the N-terminus of any other steroid hormone receptor (Andersen et al Cancer Cell 2010; Myung et al JCI 2013). Validation of the novelty of her drug was provided by the USAN council and her drug was given a new stem class “-aniten” and the generic name “ralaniten”. In 2016, Dr. Sadar developed the first imaging agent to detect androgen receptor and its active splice variants in prostate cancer (Imamura et al JCI Insight 2016).

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

Leung, Victor

Portrait photo of Victor Leung

Leung, Victor

MD, FRCPC

Academic Rank(s): Clinical Professor, Pathology and Laboratory Medicine, UBC | Medical Director, Infection Prevention and Control, Medical Lead, Antimicrobial Stewardship Program

Affiliation(s): St. Paul’s Hospital

Research and Scholarly Interests: Infectious Diseases and Immunology Microbiology, Antimicrobial Stewardship, Implementation science

Clinical Interests:

vleung@providencehealth.bc.ca

Short Bio
OpenClose

Victor Leung was born at St. Paul’s Hospital and grew up in Vancouver. After medical school and residency in Internal Medicine at UBC, he moved to Montreal and completed a combined fellowship in Medical Microbiology and Infectious Diseases at McGill University. Victor returned to Providence Health Care in 2011 and worked in Infection Prevention and Control, Medical Microbiology laboratory and the Infectious Diseases Consultation service. He was offered the exciting opportunity to lead and implement the Antimicrobial Stewardship Program in April 2013.

 

Academic
OpenClose

Academic Background

  • FRCPC Medical Microbiology. 2011
  • McGill University, Fellowship, Infectious Diseases and Medical Microbiology. 2011
  • FRCPC Infectious Diseases. 2010
  • FRCPC Internal Medicine. 2009
  • University of British Columbia, Residency, Internal Medicine. 2008
  • University of British Columbia, MD. 2005
  • University of British Columbia, B.Sc (Hons). 2001
  • McGill University, Fellowship, Infectious Diseases and Medical Microbiology. 2011

Awards and Recognition

Publications

Selected Publications

Research
OpenClose

Research Interest

  • Antimicrobial Stewardship
  • Nosocomial infections
  • Implementation science

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

  • Infection Prevention and Control practice
  • Diagnostic test utilization
  • Rational antimicrobial prescribing

Godolphin, William

Godolphin, William

PhD

Academic Rank(s): Professor Emeritus, Pathology and Laboratory Medicine, UBC

Affiliation(s): UBC Hospital

Research and Scholarly Interests: Scholarship of Teaching of Education Research

Clinical Interests:

wgod@mail.ubc.ca

Short Bio
OpenClose

 

Academic
OpenClose

Academic Background

  • Fellow of the Canadian Academy of Clinical Biochemists. 1986
  • University of Alberta. PhD (Clinical Biochemistry) 1974
  • Teaching Certificate, Manitoba Department of Education.  1962-1969
  • University of Manitoba at Brandon College. BSc (General Science) 1962

Awards and Recognition

  • The Dr. Philip E Reid Memorial Cup for Outstanding Contribution [to the Bachelor of Medical Laboratory Science Program, Department of Pathology, UBC], awarded by the students of the Class of 2006. May 26, 2006
  • Boehringer Mannheim Award for Excellence in Research on Novel Concepts in Clinical Laboratory Automation with Emphasis on the Pre-Analytical Phase. Awarded to Karin Bodtker, Llynda Wilson, William Godolphin at the International Conference on Advanced Robotics. Jan 27, 1994
  • MDS Health Group Award, Canadian Society of Clinical Chemists. 1986
  • Pioneer in Laboratory Robotics, Presented in recognition of scientific and technological contributions at the International Symposium on Laboratory Robotics. 1989
  • Medical Research Council of Canada Studentship. 1970-1974

Awards for Service:

  • Life Member, Association for Laboratory Automation. Jan 2000

Publications

Selected Publications

  • Kline C, Godolphin W, Chhina* G, Towle A. Community as Teacher: health professional students learn cultural safety from an Aboriginal community. Michigan Journal of Community Service Learning 2013; 20(1): 5-17.
  • Towle A, Godolphin W. Patients as educators: interprofessional learning for patient-centred care. Medical Teacher 2013, 35(3); 219-225.
  • Towle A, Godolphin W. The neglect of chronic disease self-management in medical education: Involving patients as educators. Academic Medicine 2011; 86: 1350.
  • Towle A, Godolphin W. A meeting of experts: the emerging roles of non-professionals in the education of health professionals. Teaching in Higher Education 2011; 16(5): 495-504.
  • Towle A, Bainbridge L, Godolphin W, Katz A, Kline C, Lown B, Madularu I, Solomon P, Thistlethwaite J. Active patient involvement in the education of health professionals. Medical Education 2010; 44: 64-74.
  • Godolphin W. Shared decision-making. Healthcare Quarterly 2009; 12 Special Issue: e186-e190.
  • Kindler P, Grant* C, Kulla* S, Poole G, Godolphin W. Difficult incidents and tutor interventions in problem-based learning tutorials. Medical Education 2009; 43: 866-873.
  • Towle A, Godolphin W, Grams G, LaMarre* A. Putting informed and shared decision making into practice. Health Expectations 2006 Dec; 9(4): 321-32.
  • Towle A, Godolphin W, Alexander* T. Doctor-patient communications in the Aboriginal community: towards the development of educational programs. Patient Education and Counseling 2006 Sep; 62(3): 340-6.
  • Towle A, Godolphin W, Van Staalduinen* S. Enhancing the relationship and improving communication between adolescents and their health care providers: a school based intervention by medical students. Patient Education and Counseling 2006 Aug; 62(2): 189-92.
Research
OpenClose

Research Interest

Research and Development

Development and implementation of robotic systems and other automation for the clinical laboratory and study of their impact. Involvement in entrepreneurial activity focused on the invention and development of automation and tools for evaluation of its effect. (1983-1993)

Medical informatics and information exchange between the public and private sector with a focus on the patient (partly connected with the Hospital Without Walls project). Focus of sabbatical in 1994-95 was the patient held medical record as a conceptual model for the management of information exchange with an emphasis on issues of technology, education, design, ethics and privacy (1994-1997)

Development of programs for medical students, continuing medical education of practising physicians and for patients, aimed at communication skills necessary to engage in doctor-patient encounters leading to informed and shared decision making. This research and development project, begun in 1996, is concerned with fundamental problems of doctor-patient communications, with the presentation and sharing of evidence-based information and with patient involvement in the decision-making process when medical/surgical management is being considered. (1996-present)

Research and Service Development

Built up a program for routine estrogen receptor collection and assay such that about 85% of all breast biopsies in the province are analyzed. Extensive follow-up permitted studies of the epidemiology and prognostic importance of hormone-receptor measurements and international collaboration in research on other markers of breast cancer prognosis. (1975-1997)

Clinical pharmacokinetics and analytical toxicology as they relate to dose predictions and management of seizure disorders and overdose toxicity. (1976-1996)

Trace metal pathophysiology and analysis related to nutrition, immunity, and neurological disorders (especially Zn, Cu, Al, Pb and Mn). (1979-1993)

Service Development and Operational Responsibility:

Management of Vancouver General Hospital clinical chemistry laboratory with particular responsibility for sections dealing with R&D, toxicology, therapeutic drug monitoring, trace metal analysis and tissue receptor analyses. (1974-1996)

Review and supervision of all research and development projects operated in or supported by the routine clinical chemistry laboratory at the Vancouver General Hospital. (1977-1996)

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

BMLSc course in Medical Laboratory Toxicology from 1985 to 2007

PATH 405 – This required seminar course was a part of the original BMLSc program. Beginning in 1984, together with the then-coordinator, Phil Reid, I began to redesign this course to teach the students how to teach, perform peer- and self-assessment, and critically appraise scientific literature. I coordinated and team taught this course with Dr Reid, then with Dr Carol Park (since 1993) and Dr Amanda Bradley (since 2006) and Dr Hanh Huynh (since 2008). In 2006 I ceased to coordinate the course but continue to teach it.

PATH 201 & 202 – I designed and coordinated these two courses, to meet the need for an introduction to medical laboratory sciences by science students entering the BMLSc program with no prior experience in clinical laboratories. (Prior to this the incoming students all had laboratory technologist training.)

INDE 453 – This “Effective learning skills for medical practice” course is a required final year course for MD undergraduate students. It contains a series of modules on “advanced communication skills”. I was a member of the committee that designed this program and the creator of a component on “Doctor-patient communication for shared decision making and informed consent” – including trigger videos, standardized patient scenarios, assessment instruments and tutor guidelines.

Group Facilitation

I received training as a creative planning facilitator at The Training Group Institute (Vancouver) in 1986 and have been intermittently active as facilitator for retreats, planning days, etc., for many departments, divisions and organizations associated with UBC.

Process in Problem Based Learning

I provided ‘tutor support’ for problem-based learning (PBL) tutors in the UBC Faculty of Medicine undergraduate curriculum since the change to PBL in 1997 until 2006. I have been especially interested and active in the development of practices and resources that help tutors and students to ‘do’ PBL with enjoyment and good learning. In this way I have tried to be a ‘coach’ and advocate for the tutors. Many of the current practices for tutor meetings, tutor observations, and assessments of tutors and assessment of students were introduced and guided by me. This includes various research and development projects to provide teaching-learning aids (e.g., videotapes, manuals of tips & techniques) and various workshops and seminars for tutors (e.g., on giving feedback and solving problems in group dynamics).

Teaching Teachers to Teach

I had a special interest and activity in TIPS (Teaching Improvement Program Systems) program coordinated by the Division of Education Support & Development. Beginning in 1984 with three other faculty, and steadily recruiting others to be trained and then assist, I presented 1-4 day workshops to help faculty improve their teaching skills (about 40 workshops 1984-1999) at UBC and affiliated hospitals. I also presented workshops and helped to spread the program across Canada (Alberta, Saskatchewan, Manitoba, Ontario, Quebec and Newfoundland), and internationally (West Indies, UK and Australia), through ‘train the trainer’ activity. The Teaching & Academic Growth Instructional Skills Workshops at UBC had its origin in this program. In 2007 the UBC TIPS team was awarded the AFMC-AstraZeneca Award for Exemplary Contribution to Faculty Development – recognizing especially the outreach to other medical schools across Canada. I also redesigned the program and with the help of other Pathology faculty have presented as a course for students in the final year of the BMLSc program (under the designation of Pathology 405). This course is unique at UBC in that all the students of this program acquire high-level teaching skills before graduation.

Rakic, Bojana

Rakic, Bojana

PhD, FCCMG (Biochemical Genetics)

Academic Rank(s): Clinical Professor, Pathology and Laboratory Medicine, UBC | Investigator, BC Children’s Hospital | Biochemical Geneticist, Biochemical Genetics and Newborn Screening Laboratories, BC Children’s Hospital and BC Women’s Health Centre of BC

Affiliation(s): BCCH/BCCHRI

Research and Scholarly Interests: Clinical Applied Research, Inherited Metabolic Disorders/Inborn errors of metabolism, Newborn screening, Diagnostic Methods, Mass spectrometry / Metabolomics, Immunometabolism, Quality Improvement

bojana.rakic@cw.bc.ca

Short Bio
OpenClose

Dr. Bojana Rakic is a Biochemical Geneticist at BC Children’s Hospital. She is the Director of the Biochemical Genetics Laboratory and a Training Program Director for the Laboratory Biochemical Genetics Fellowship Program in BC. Her interests are in applied research related to developing novel diagnostic tests for investigating and monitoring patients with inherited metabolic disorders, as well as in translational research aiming to understand pathophysiology of these disorders.

 

Academic
OpenClose

Academic Background

  • Fellowship (CCMG, Biochemical) University of British Columbia.  2015
  • NSERC Postdoctoral Research Fellowship, University of British Columbia. 2012
  • PhD (Biological Chemistry), University of Ottawa / NRC. 2007
  • BSc (Chemistry), University of Belgrade, Serbia. 2000

Awards and Recognition

Publications

Selected Publications

Research
OpenClose

Research Interest

  • Inborn errors of metabolism
  • Newborn screening
  • Mass spectrometry / Metabolomics
  • Immunometabolism
  • Quality Improvement

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

  • BSMLs: PATH 301 Basic and Physical Biochemistry for Medical Laboratory Scientists
  • MEDG 575 Advanced Clinical Rotation: Course Lead for Biochemical Genetics
  • CCMG Training Program Director, UBC Biochemical (Laboratory) Genetics Post-graduate fellowship program

Mack, Benjamin

Mack, Benjamin

MD FRCPC

Academic Rank(s): Clinical Instructor, Medical Director, Pathology and Laboratory Medicine, UBC | Site Medical Lead, Infection Prevention and Control, Surrey Memorial Hospital and Langley Memorial Hospital

Affiliation(s): Surrey Memorial Hospital

Research and Scholarly Interests: Molecular Pathology and Cell Biology, Scholarship of Teaching of Education Research

Clinical Interests:

ben.mack@fraserhealth.ca

Short Bio
OpenClose

 

Academic
OpenClose

Academic Background

  • Subspecialty Training (Infectious Diseases and Medical Microbiology), University of Alberta. 2001-2004
  • Residency, Internal Medicine (completed in 2002 at University of Alberta co-incident with subspecialty training),
  • Dalhousie University, Halifax, NS. 1998 – 2002
  • MD (Medicine),University of Alberta. 1994 – 1998
  • Graduate studies (Neuroscience), Department of Pharmacology, University of Alberta. 1992-1994
  • BA (Psychology (Honours)), University of Alberta. 1987 – 1991

Professional Qualifications

  • RCPSC Specialist Certification in Medical Microbiology. 2004
  • College of Physicians and Surgeons of British Columbia Licentiate. 2004
  • RCPSC Subspecialty Certification in Infectious Diseases. 2003
  • Fellow of the Royal College of Physicians and Surgeons of Canada. 2003
  • College of Physicians and Surgeons of Alberta Licentiate. 2003
  • RCPSC Specialist Certification in Internal Medicine. 2002
  • Medical Council of Canada Licentiate. 2000
Qingdao Medical College, Qingdao, China. 1983

Awards and Recognition

Awards for Scholarship

  • Dean’s Research Fund, University of Alberta, Faculty of Medicine

Awards for Service

  • Chief Resident, Medical Microbiology, University of Alberta, 2003 – 2004
  • Residency Training Committee, Substitute Representative, Dalhousie University Department of Medicine, 1999
  • Communications Officer, University of Alberta Medical Students’ Association, 1995 – 1996

Other Awards

  • Annual Best Abstract Award, Division of Infectious Diseases Abbott Laboratories Ltd., (for Best Abstract by an
  • Infectious Diseases or Medical Microbiology Subspecialty Trainee at University of Alberta), 2003
  • George McCracken Infectious Disease Fellow Travel Grant, American Society for Microbiology, To attend 42nd
  • Interscience Conference on Antimicrobial Agents and Chemotherapy, 2002
  • Second Prize in Subspecialty Resident Poster Presentations, University of Alberta, Department of Medicine Research Day, 2002
  • Rick Hansen Man in Motion Legacy Fund, 1992
  • Dean’s Honour Roll, University of Alberta, Faculty of Science, 1990, 1991
  • Summer Student Research Fund, National Sciences and Engineering Research Council, 1990

Publications

Selected Publications

  • Forrest DL, Mack BJ, Nevill TJ, Couban SH, Zayed E, Foyle A. Bone marrow necrosis in adult acute leukemia and non-Hodgkin’s lymphoma. Leuk Lymphoma. 2000 Aug;38(5-6):627-32.
Research
OpenClose

Research Interest

  • Antibiotic stewardship and utilization in hospitals
  • Quality control assessment and maintenance in consolidation of microbiology laboratories
  • Clinical-laboratory interaction, and optimal utilization of laboratory resources; innovative methods for service delivery by medical microbiologists

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

Tan, Kennard

Tan, Kennard

BSc, MD

Academic Rank(s): Clinical Assistant Professor, Pathology and Laboratory Medicine, UBC | Medical Microbiologist and Medical Lead of Analytics, Royal Jubilee Hospital

Affiliation(s): Royal Jubilee Hospital

Research and Scholarly Interests: Genetics genomics proteomics and related approaches, Infectious Diseases and Immunology Microbiology, Informatics

Clinical Interests:

Kennard.tan@viha.ca

Short Bio
OpenClose

I’m a medical microbiologist who is involved in using health informatics and data analytics to improve the delivery, efficiency and quality of laboratory diagnostics. Currently, I am the Medical Lead of Analytics for BC’s Agency of Pathology and Laboratory Medicine, which is within PHSA, and also work as a medical microbiologist at Fraser Health. I completed my Medical Degree at the University of Alberta, my medical microbiology residency at UBC, and post-residency fellowship at the Johns Hopkins Hospital in Baltimore. I worked for Island Health in Victoria from 2012 to 2017 as a medical microbiologist and as the Physician Lead for Clinical Analytics for the IHealth project. While in Victoria, I completed a Masters in Health Information Science at the University of Victoria, with a thesis is on the use of computerized clinical decision support tools for infection control. Presently, I am involved in multiple projects related to robotics, health informatics and data analytics. I cannot imagine a more exciting time to be working, as all these fields will change the way we diagnose and manage infections. Outside of work, I enjoy the challenges of being a new father as my children do not follow a predictable algorithm or sensible logic as my work.

 

Academic
OpenClose

Academic Background

  • MSc (Health Information Science), University of Victoria. 2011 – present
  • Fellowship. Research-fellowship in Medical Microbiology. Johns Hopkins Hospital. 2011 – 2012
  • Residency. Post-Grad training for Medical Microbiology. University of British Columbia. 2006 – 2011
  • MD (Doctor of Medicine), University of Alberta. 2002 – 2006
  • BSc (Life Sciences, Molecular Biology (via Integrated Sciences Program)), The University of British Columbia. 1996 – 2000

Professional Qualifications

  • FRCPC – Medical Microbiology. 2011
  • Diplomate of the American Board of Medical Microbiology. 2010

Awards and Recognition

  • Johns Hopkins Pathology: Pathology Young Investigators’ Day Award in Clinical Research. May 2012
  • Infectious Disease Society of America: Travel grant for poster presentation at conference. Oct 2010
  • European Congress of Clinical Microbiology and Infectious Diseases: Registration grant for poster presentation at conference. Apr 2010

Publications

Selected Publications

  • Prospective Evaluation of a Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry System in a Hospital Clinical Microbiology Laboratory for Identification of Bacteria and Yeasts: a Bench-by-Bench Study forAssessing the Impact on Time to Identification and Cost-Effectiveness. Tan KE, Ellis BC, Lee R, Stamper PD, Zhang SX, Carroll KC. (J Clin Microbiol. 2012 Oct;50(10):3301-8).
  • Cryptococcus gattii infections with cutaneous involvement. Mistry N, Tan K, Shokravi M, Hoang L. (Journal of Cutaneous Medicine and Surgery 2011 Jul-Aug; 15(4): 236-7).
  • Mumps virus detection during an outbreak in a highly unvaccinated population in British Columbia. Tan KE, Anderson M, Krajden M, Petric M, Mak A, Naus M. (Canadian Journal of Public Health 2011 Jan-Feb; 102(1): 47-50).
  • Toxoplasmosis. Wright AJ, Tan KE, Alghamdi FA, Mackenzie IR, Isaac-Renton J, Morshed M. (ASCP Check Sample 2011, In Press).
  • Trichosporon species: Classification, Identification, and Clinical Relevance. Tan K, Grant J. (American Society for Clinical Pathology – Check Sample: Microbiology 2010 Aug; 53(6): 61-71).
  • Answer to case of the month #114 intrapericardial diaphragmatic hernia (IPDH). Tan KE, Marshall GB, Burrowes P, Gray R. (Canadian Association of Radiologist Journal 2006 Dec; 57(5): 303-5).
  • Carboplatin and Vinblastine for the Treatment of Metastatic Transitional Cell Carcinoma of the Urothelial Tract. Al-Karim HA, Tan KE, Chi KN, Bryce CJ, Murray NR, Coppin C. (American Journal of Clinical Oncology 2002 Oct; 25(5): 515-9).
Research
OpenClose

Research Interest

  • Medical Microbiology & Infectious Diseases – including Infection Control & Antimicrobial Stewardship
  • Advanced Diagnostic Methods – MALDI-TOF MS & Molecular Methods
  • Health Informatics

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

Laule, Cornelia

Laule, Cornelia

BSc, MSc, PhD

Academic Rank(s): Professor, Department of Radiology and Pathology & Laboratory Medicine, Faculty of Medicine, UBC | MR Physicist, Blusson Spinal Cord Centre/ICORD and DMCBH

Affiliation(s): ICORD and DMCBH

Research and Scholarly Interests: Brain,spinal cord, myelin, MRI, histology, axons, neurodegeneration, neuroinflammation, microscopy, imaging,multiple sclerosis, spinal cord injury, neurology, radiology, pathology, physics, image processing, image analysis, aging

Clinical Interests: application of magnetic resonance imaging (MRI) in the clinical setting, particularly for understanding and diagnosing conditions like multiple sclerosis and spinal cord injuries

claule@physics.ubc.ca

Short Bio
OpenClose

Dr. Cornelia (Corree) Laule is a physicist and has been involved with nuclear magnetic resonance and magnetic resonance imaging (MRI) research for 22 years. She completed a post-doctoral fellowship with Dr. Wayne Moore in the Department of Pathology & Laboratory Medicine where her research focused on MRI pathology correlation studies in multiple sclerosis (MS) brain tissue. Dr. Laule was appointed as an Assistant Professor in the Faculty of Medicine in January 2013 and promoted with tenure in July 2019.

Academic
OpenClose

Academic Background

  • Post doctoral fellowship, Department of Pathology & Laboratory Medicine, University of British Columbia (2010-2012)
  • Research Associate, Department of Radiology, University of British Columbia (2005-2010)
  • PhD (Physics), University of British Columbia (2001-2005)
  • MSc (Physics), University of British Columbia (1999-2001)
  • BSc (Major: Physics, Minor: German), University of British Columbia (1994-1999)

Awards and Recognition

Publications

 

Publications

Research
OpenClose

Research Interest

Dr. Laule is interested in understanding the microstructural and pathological determinants which govern T1 and T2 relaxation measures in central nervous system (CNS) tissue. Her primary area of research is MS and she has extensive experience in imaging both in vivo and post mortem MS brain and spinal cord, with emphasis on characterizing myelin. She also collaborates to study many other CNS applications including spinal cord injury, schizophrenia, cerebral malaria, bipolar disorder, leukodystrophies and Huntington’s disease, as well the characterization of normal controls. She is particularly interested in myelin and has future plans to use biochemical analysis and electron microscopy to understand how variations in myelin composition and structure may influence to MRI measures.

Dr. Laule’s quantitative MRI-pathology correlations validated myelin water imaging as a marker for myelin when her histopathological studies revealed a strong correlation between the MR and histopathological measures of myelin.

In one of the few studies examining myelin water serially in the human spinal cord, Dr. Laule’s research showed that people with primary progressive MS showed a 10% decrease in myelin over two years, while the controls remained stable. This suggests that progressive demyelination occurs and myelin water may help follow the pathological processes that contribute to clinical disability in progressive multiple sclerosis.

Dr. Laule’s studies of diffusely abnormal white matter reveal evidence of a primary lipid abnormality with little protein involvement. This raises the possibility of a primary role for lipid in the autoimmune or degenerative etiopathogenesis of MS, studies of which up to now have largely focused on myelin protein immunology and biology. Thus, examining the tissue changes underlying DAWM may identify substrates responsible for disability and progression, which could be a target for future therapies.

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

Imperial, Miguel

Imperial, Miguel

MD MHSc D(ABMM) FRCPC

Academic Rank(s): Clinical Assistant Professor, Pathology and Laboratory Medicine, UBC | Medical Microbiologist Clinical Consultant – Complex Chronic Diseases Clinic, BC Women’s Hospital and Health Centre | Medical Microbiologist Consultant, LifeLabs, Medical Microbiologist, BCCDC

Affiliation(s): LifeLabs

Research and Scholarly Interests: Infectious Diseases and Immunology Microbiology, Parasitology, Tropical and travel medicine, Proteomics

Clinical Interests:

miguelri@mail.ubc.ca

Short Bio
OpenClose

Dr. Miguel Imperial MD MHSc D(ABMM) FRCPC is a specialist physician in the discipline of Medical Microbiology, a field which deals with the diagnosis and treatment of infections due to bacterial, viral and parasitic agents. He is certified by the Royal College of Physicians and Surgeons of Canada and the American Board of Medical Microbiology and holds a Certificate of Knowledge in Travel Medicine and is a member of the American Society of Tropical Medicine and Hygiene. He completed medical school and specialty training at the University of British Columbia and did additional training in Tropical Medicine at Johns Hopkins School of Public Health in Baltimore, Maryland.

 

Academic
OpenClose

Academic Background

  • Doctor of Medicine (MD), University of British Columbia, 2005
  • Masters of Health Science (MHSc), University of British Columbia, 2008
  • Tropical Medicine, Bloomberg School of Public Health, Johns Hopkins University, 2009
  • Diplomate of the American Board of Medical Microbiology D(ABMM), 2010
  • FRCPC, Medical Microbiology, University of British Columbia, 2010

Awards and Recognition

Publications

Selected Publications

  • Yatham, Lakshmi N, Vesna Sossi, Marcia Kauer-Sant’Anna, Thomas J Ruth, Miguel Imperial, Peter F Liddle, Jonathan Erez and Raymond W Lam. “Brain serotonin-2 receptors in acute mania.”. 196.1 (Jan, 2010): 47 – 51, .
  • Imperial, Miguel and Neil Reiner. “Aggregatibacter actinomycetemcomitans: Taxonomy Changes, Illness, Laboratory Diagnosis, and Treatment”. AMERICAN JOURNAL OF CLINICAL PATHOLOGY. Checksample (2009).
  • Imperial, Miguel and Pamela Kibsey. “Rat Bite Fever and Haverhill Fever Due to Streptobacillus moniliformis: Recognition of the Clinical Syndromes, Laboratory Diagnosis, and Treatment”. AMERICAN JOURNAL OF CLINICAL PATHOLOGY. Checksample (2008).
Research
OpenClose

Research Interest

Research and Clinical Interest

  • Parasitology
  • Tropical and travel medicine
  • Public health interventions in the developing world
  • Proteomics, MALDI-TOF and molecular methods in clinical microbiology
  • Specialty: Medical Microbiology

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

Dr. Imperial continues to lectures at the UBC medical school and serves as Week 5 Chair in the Medical Microbiology and Infectious Diseases block, assisting with course development. He also teaches virology for the Bachelor of Medical Laboratory Science courses at UBC. He remains involved with supervising and teaching medical residents in their specialty training.

Hauff, Kristin

Portrait photo of Kristin Hauff

Hauff, Kristin

PhD

Academic Rank(s): Clinical Assistant Professor, Pathology and Laboratory Medicine, UBC | Clinical Biochemist, Kelowna General Hospital

Affiliation(s): Kelowna General Hospital

Research and Scholarly Interests: Knowledge translation, Molecular Pathology and Cell Biology, Scholarship of Teaching of Education Research, Toxicology, Autoimmunity, High volume chemistry, Protein electrophoresis,Quality Assurance

Clinical Interests:

kristin.hauff@interiorhealth.ca

Short Bio
OpenClose

Dr. Hauff completed a Bachelor of Science with a Major in Microbiology at the University of Manitoba (2001). She obtained her PhD in Pharmacology & Therapeutics from the University of Manitoba (2009) on the topic of Hypocholesterolemia in Barth Syndrome. She then completed a post-doctoral fellowship in Clinical Chemistry at McMaster University (2012).

Dr. Hauff has published numerous peer-reviewed papers and abstracts at international conferences, receiving various awards in research excellence. Dr. Hauff has been an invited speaker at conferences, community groups, and lectured at both the graduate and undergraduate university level at the University of Manitoba and McMaster Universities. Most recently, Dr. Hauff received a cross appointment as a Clinical Instructor in the Department of Pathology and Laboratory Medicine at University of British Columbia. Dr. Hauff joined Kelowna General Hospital in 2018.

 

Academic
OpenClose

Academic Background

  • Diploma, Post-doctoral Training Program in Clinical Chemistry, McMaster University. 2012
  • PhD, University of Manitoba, Dept of Pharmacology & Therapeutics. 2009
  • BSc (honours), University of Manitoba. 2001

Awards and Recognition

Publications

Selected Publications

Research
OpenClose

Research Interest

  • Toxicology
  • Autoimmunity
  • High volume chemistry
  • Protein electrophoresis
  • Quality Assurance

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

DeMarco, Mari

DeMarco, Mari

PhD, DABCC

Academic Rank(s): Clinical Professor, UBC, Department of Pathology and Laboratory Medicine | Clinical Chemist, Providence Health Care

Affiliation(s): St. Paul’s Hospital / HLI

Research and Scholarly Interests: Development of new biofluid diagnostic tests for Alzheimer’s disease and related forms of dementia. Advancing clinical diagnostics for neurodegenerative disorders such as Alzheimer’s disease and frontotemporal dementia. New methodological approaches for identification and quantitation of protein biomarkers of health and disease, with a focus on clinical mass spectrometric analysis of peptide and protein biomarkers.

Clinical Interests: Clinical chemistry, with a particular emphasis on the clinical mass spectrometric analysis of peptide and protein biomarkers. Implementation of novel diagnostic tests in patient care, focusing on improving tools for timely diagnosis of neurodegenerative diseases. Bridging basic biomedical science, analytical chemistry, and laboratory medicine to impact patient care.

mdmrco@mail.ubc.ca

Short Bio
OpenClose

Dr. DeMarco received a BSc in Honours Biochemistry and a minor in Mathematics from Mercyhurst University. She earned a PhD from the University of Washington in Medicinal Chemistry, as part of the Biomolecular Structure and Design Program. She subsequently completed a Clinical Chemistry fellowship at Washington University School of Medicine in St Louis.

Dr. DeMarco’s research group is interested in technology development and implement of novel diagnostic tests for use in patient care, with an emphasis on clinical mass spectrometric analysis of peptide and protein biomarkers. While the group works in various areas of medicine, a major focus is on neurodegenerative diseases. The group aims to create better tools for timely diagnosis of Alzheimer’s disease, frontotemporal degeneration, and related disorders, and make these tools easily accessible to those that need them. New tests are needed to improve our understanding of disease pathology and progression, support clinical trials for new therapeutics, and help provide timely and accurate diagnoses. This research is accomplished in close collaboration with clinicians and scientists at UBC’s Clinic for Alzheimer’s Disease and Related Disorders.

Clinical Chemist, St Paul’s Hospital
Clinical Professor, University of British Columbia
Michael Smith Foundation for Health Research Scholar

DeMarco Lab

 

Academic
OpenClose

Academic Background

  • Clinical Chemistry Fellowship, Washington University School of Medicine. 2013
  • Postdoctoral Fellowship (Complex Carbohydrate Research Center), University of Georgia. 2010
  • PhD (Medicinal Chemistry, Biomolecular Structure and Design Program), University of Washington. 2006
  • BSc (Honors Biochemistry), Mercyhurst College. 2001

Awards and Recognition

Dr. Mari DeMarco recently received the 2022 Award for Research Excellence from the Canadian Society of Clinical Chemists and the 2022 Bereman Award for Innovative Clinical Proteomics from the Association for Mass Spectrometry & Advances in the Clinical Lab​

Publications

PUBMED Dr. DeMarco, Mari

Research
OpenClose

Research Interest

Engaged in Clinical Research?: Yes
Research Interests: Protein misfolding diseases and development of novel clinical diagnostics
Research Specialization Keywords: clinical assay development, clinical chemistry, immunoassays, mass
spectrometry, protein misfolding & amyloid formation, translational medicine
Research Centres: Providence Health Care Research Institute, The James Hogg iCAPTURE Centre for
Cardiovascular and Pulmonary Research
Technological Applications: Clinical biological analyses
Disciplines Trained In: Biochemistry, Chemistry, Pathology, Statistics
Research Disciplines: Biochemistry, Chemistry, Pathology
Areas of Research: Biomedical Technologies, Neurodegenerative Diseases, Pathology, Proteins, Proteomics
Fields of Application: Biomedical Aspects of Human Health, Pathogenesis and Treatment of Diseases

Dr. DeMarco’s lab at St. Paul’s Hospital collaborates closely with clinicians and scientists to translate new biomedical discoveries into patient care, especially in the realm of neurodegenerative diseases​

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

  • Laboratory based teaching

Kirby, Shane

Kirby, Shane

Academic Rank(s): Clinical Instructor, Pathology and Laboratory Medicine, UBC | General Pathologist, Burnaby Hospital

Affiliation(s): Burnaby Hospital, Laboratory

Research and Scholarly Interests: Infectious Diseases and Immunology Microbiology, Infection Control

Clinical Interests:

shane.kirby@fraserhealth.ca

Short Bio
OpenClose

I completed my PhD in Microbiology and Infectious Disease in 2000 and my medical degree in 2003, both at the University of Calgary. I came to Vancouver the same year, completed a residency in General Pathology, and have been working as a general pathologist at Burnaby Hospital since 2009. I recently became a member of the board of directors of the Pacific Northwest Society of Pathologists.

 

Academic
OpenClose

Academic Background

  • FRCPC (General Pathology)
  • Medical General Practice License (BC)
  • Licentiate of the Medical Council of Canada
  • MD, University of Calgary. 2003
  • PhD, University of Calgary (Microbiology and Infectious Diseases). 2000
  • BSc, University of Calgary (Cellular, Molecular and Microbial Biology, Ecology). 1993

Awards and Recognition

Publications

Selected Publications

  • Yuen, V.T.H., Kirby, S.D., Woo, Y.C. Leiomyosarcoma of the epididymis: report of two cases and review of the literature. Can. Urol. Assoc. J. 5(6): E121-E124. 2011
  • Kirby, S.D. General Pathology Program. UBC Pathology Newsletter, Fall/Winter 2007/2008, 31.
  • Khan, A.G., Shouldice, S.R., Kirby, S.D., Yu, R-H., Tari, L.W. and A.B. Schryvers. High-affinity binding by the periplasmic iron-binding protein from Haemophilus influezae is required for acquiring iron from transferrin. Biochem, J. 404: 217-225. 2007
  • Law, J.K., Amar, J.N., Kirby, S.D., Zetler, P.J. and R.A. Enns. Colonic cryptococcus infection. Gastrointestinal Endoscopy. 65(3): 525-526. 2007
  • S.D. Kirby. Bite Wounds: The Pasteurellaceae and other challenging organisms. American Society for Clinical Pathology Check Sample. 50(1): 1-15. 2007
  • Shouldice, S.R., Dougan, D.R., Williams, P.A., Skene, R.J., Snell, G., Scheibe, D., Kirby, S.D., Hosfield, D.J., McRee, D.E., Schryvers, A.B. and L.W. Tari. Crystal structure of Pasteurella haemolytica ferric ion binding protein A reveals a novel class of bacterial iron-binding proteins. Journal of Biological Chemistry. 278(42): 41-93-41098. 2003
  • Lam, S.L., Kirby, S.D. and A.B. Schryvers. Foreign signal peptides can constitute a barrier to functional expression of periplasmic proteins in Haemophilus influenzae. Microbiology 149: 3155-3164. 2003
  • Kirby, S.D., Lainson, F.A., Donachie, W., Okabe, A, Tokuda, M., Hatase, O. and A.B. Schryvers. The Pasteurella Haemolytica 35 kDa iron regulated protein is an FbpA homologue. Microbiology. 144(12): 3425-3436. 1998
  • Khun, H.H., Kirby, S.D., and B.C. Lee. A Neisseria meningitidis fbpABC mutant is incapable of using non-heme iron for growth. Infection and Immunity. 66(5): 2330-2336. 1998
  • Kirby, S.D., Gray-Owens, S.D. and A.B. Schryvers. Characterization of a ferric-binding protein mutant in Haemophilus influenzae. Molecular Microbiology. 25(5): 979-987. 1997
Research
OpenClose

Research Interest

I have an interest in microbiology and infection control practice, and until recently had been active as the Chair of the Burnaby Hospital Infection Control Committee.

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

UBC Medical Students CPC

Lau, William

Portrait photo of William Lau

Lau, William

MD, FRCPC

Academic Rank(s): Clinical Instructor, Pathology and Laboratory Medicine, UBC

Affiliation(s): Royal Columbian Hospital

Research and Scholarly Interests:

Clinical Interests:

William.Lau@fraserhealth.ca

Short Bio
OpenClose

 

Academic
OpenClose

Academic Background

  • FRCPC – General Pathology (UBC) 2003
  • MD – UBC 1996

Awards and Recognition

Publications

Selected Publications

Research
OpenClose

Research Interest

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

Prystajecky, Natalie

Prystajecky, Natalie

/p>

Academic Rank(s): Clinical Associate Professor, Pathology and Laboratory Medicine, UBC | Environmental Public Health Microbiologist, Provincial Health Services Authority and University of British Columbia

Affiliation(s): BC Centre for Disease Control

Research and Scholarly Interests: Infectious Diseases and Immunology Microbiology, Knowledge translation, Public health, Environmental Microbiology, Drinking Water, Food Quality, Genomics, Molecular Diagnostics

Clinical Interests:

natalie.prystajecky@bccdc.ca

Short Bio
OpenClose

Dr. Natalie Prystajecky is an Environmental Microbiologist at the BCCDC Public Health Laboratory and a Clinical Associate Professor in Pathology and Laboratory Medicine at the University of British Columbia. Her work is at the intersect of environmental exposures (food and water) and clinical outcomes. She uses emerging technologies to improve routine surveillance and outbreak investigations for foodborne and waterborne pathogens. she has received grant funding from the BCCDC Foundation, Canadian Water Network, NSERC, Genome BC and Genome Canada. Her current research interests include development of new water quality tests using metagenomics, targeted resequencing of wetland sediments to study the emergence of avian influenza strains and whole genome sequencing of Giardia and Salmonella. She is keen to promote the translation of research methods to routine testing in diagnostic and reference laboratories.

 

Academic
OpenClose

Academic Background

  • PhD, University of British Columbia. 2010
  • Watershed Management, University of British Columbia. Certificate. 2008
  • BSc, University of Calgary. Cellular, Molecular and Microbiology (CMMB). 2003
  • BSc, University of Calgary. Environmental Science – Biology Focus. 2003

Awards and Recognition

  • Institute of Infection and Immunity (CIHR-III) Doctoral Research Award, Canadian Foundation for Infectious Disease (CFID)/Canadian Institute for Health Research. 2006-200
  • Senior Trainee Top-Up Award, Michael Smith Foundation for Health Research (MSFHR). 2006-2008
  • University of British Columbia PhD Tuition Award, University of British Columbia. 2005-2009

Publications

PUBMED Dr. Natalie Prystajecky

Selected Publications

Research
OpenClose

Research Interest

Specialties: Public health, environmental microbiology, drinking water, food quality, genomics, molecular diagnostics

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

Shiau, Carolyn

Shiau, Carolyn

MD, FRCPC, DABP

Academic Rank(s): Clinical Associate Professor, Pathology and Laboratory Medicine, UBC | Anatomic Pathologist and Dermatopathologist, Royal Columbian Hospital

Affiliation(s): Royal Columbian Hospital

Research and Scholarly Interests: Molecular Pathology and Cell Biology, Skin Conditions, Molecular Pathology of Lung Adenocarcinoma

Clinical Interests:

carolyn.shiau@fraserhealth.ca

Short Bio
OpenClose

Dr. Shiau joined the group of anatomic pathologists at Royal Columbian Hospital in the Fraser Health Authority in 2012.  In addition to participating on a busy surgical pathology service, she works as one of the regional dermatopathology consultants.  Her training includes residency in anatomic pathology at University of Toronto and fellowship in dermatopathology based at University Health Network with Dr. Danny Ghazarian with additional time at Melanoma Institute of Australia and Royal Prince Alfred Hospital with Dr. Richard Scolyer.  During her training, she represented the pathology residents and fellows of Toronto on the departmental training committees as well as Post-Graduate Medical Education Advisory Committee at University of Toronto, the College of Physicians and Surgeons of Ontario (CPSO) Education Committee, and the Board of Directors for Professional Association of Internes and Residents of Ontario (PAIRO).  She also worked as one of the resident leaders encouraging a culture of teaching in the pathology program to foster the confidence of senior residents as they learned how to be good teachers to the off-service and junior residents.

Now that she is settling into the transition from training to practice, she hopes to find more opportunities to become involved with teaching opportunities for medical students and residents at the University of British Columbia.  In her spare time, she can be found making music with various community groups or hiking/cycling through the local mountains.

 

Academic
OpenClose

Academic Background

  • Fellow in Dermatopathology, University Health Network – Toronto and Melanoma Institute of Australia – Sydney. 2011-2012
  • Certification in Anatomic Pathology, Diplomate of the American Board of Pathology, DABP. 2011
  • Certification in Anatomic Pathology, Royal College of Physicians & Surgeons of Canada, FRCPC. 2011
  • Residency, Anatomic Pathology, University of Toronto. 2006-2011
  • MD (Medicine), University of Toronto. 2002-2006
  • BSc (Honours Physics and Biology), University of British Columbia. 1999-2002

Awards and Recognition

Publications

Selected Publications

  • Shiau CJ, Babwah JP, da Cunha Santos G, Sykes JR, Boerner SL, Geddie WR, Leighl NB, Wei C, Kamel-Reid S, Hwang DM, Tsao MS. Sample features associated with success rates in population-based EGFR mutation testing. J Thorac Oncol 2014 Jul;9(7):947-56.
  • Shiau CJ, Babwah JP, da Cunha Santos G, Sykes JR, Boerner SL, Geddie WR, Leighl NB, Wei C, Kamel-Reid S, Hwang DM, Tsao MS. Sample features associated with success rates in population-based EGFR mutation testing. J Thorac Oncol 2014 Jul;9(7):947-56.
  • Haerle SK, Shiau C, Goldstein DP, Qiu X, Erovic BM, Ghazarian D, Xu W, Irish JC. Merkel cell carcinoma of the head and neck (HNMCC): Potential histopathologic predictors. Laryngoscope [ePub 2013 Jun 11]
  • Shiau CJ, Thompson JF, Scolyer RA. Controversies and evolving concepts in the diagnosis, classification, and management of lentigo maligna. Expert Review of Dermatology, Apr 2013; 8(2):195-214.
Research
OpenClose

Research Interest

  • Dermatopathology
  • Molecular Pathology of Lung Adenocarcinoma

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

  • Residency training
  • Algebraic (non-calculus) physics

Vice, Frances

Vice, Frances

MD, FRCPC

Academic Rank(s): Clinical Assistant Professor, Pathology and Laboratory Medicine, UBC

Affiliation(s): St. Paul’s Hospital

Research and Scholarly Interests: Molecular Pathology and Cell Biology, Cytology, Breast and Gyne Surgical Pathology

Clinical Interests:

fvice@providencehealth.bc.ca

Short Bio
OpenClose

I completed medical school in Hamilton, ON and split residency between Calgary, AB and London, ON. Upon finishing fellowship training in London with a special interest in Cytology, breast and gyne surgical pathology, I moved to BC in 2006 and began working at the Royal Columbian Hospital. Although my main area of interest remains cytology, I really enjoy seeing a variety of surgical pathology cases in this busy community hospital department.

Academic
OpenClose

Academic Background

Awards and Recognition

Publications

Selected Publications

Research
OpenClose

Research Interest

  • Cytology
  • Breast and Gyne Surgical Pathology

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

Yeung, Karen

Yeung, Karen

Academic Rank(s): Clinical Instructor, UBC | Head of Department (Local) – Department of Laboratory Medicine and Pathology, Royal Columbian Hospital | Site Medical Director of Immunohistochemistry, RCH

Affiliation(s): Royal Columbian Hospital

Research and Scholarly Interests:

Clinical Interests:

karen.yeung@fraserhealth.ca

Short Bio
OpenClose

 

Academic
OpenClose

Academic Background

Awards and Recognition

Publications

Selected Publications

Research
OpenClose

Research Interest

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

  • Teaching of medical students and residents

Tucker, Tracy

Tucker, Tracy

PhD, FCCMG

Academic Rank(s): Clinical Professor, Pathology and Laboratory Medicine, UBC | Clinical Molecular Geneticist & Cytogeneticist, Cancer Genetics Laboratory, BC Cancer Agency

Affiliation(s): BC Cancer Agency

Research and Scholarly Interests: Genetics genomics proteomics and related approaches, Molecular Pathology and Cell Biology, Scholarship of Teaching of Education Research

Clinical Interests:

ttucker2@bccancer.bc.ca

Short Bio
OpenClose

 

Academic
OpenClose

Academic Background

  • FCCMG Cytogenetics 2013, UBC
  • FCCMG Molecular Genetics 2012, UBC
  • Post-doctoral fellowship, Medical Genetics, 2010
  • PhD Medical Genetics 2006, UBC
  • BSc Honours Biology 2000, University of Waterlo

Awards and Recognition

  • Finalist, ASHG Charles J. Epstein Trainee Awards for Excellence in Human Genetics Research: Announcement of Winners. 2009
  • Department of Medical Genetics, UBC James Miller Memorial Award. 2006

Publications

Selected Publications

Research
OpenClose

Research Interest

  • Clinical molecular genetics and cytogenetics
  • Cancer genetics
  • Implementation and validation of new technologies for clinical application

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

  • Organize and teach month long sessions in molecular/cytogenetic testing in cancer for pathology residents at BCCA
    UBC Genetic Counseling students – cytogenetics
  • Clinical Molecular Genetics for students enrolled in the Bachelor of Medical Laboratory Science at UBC

Masoudi, Hamid

Masoudi, Hamid

MD, FRCPC

Academic Rank(s): Clinical Assistant Professor, Pathology and Laboratory Medicine, UBC | Anatomical pathologist, St. Paul’s Hospital

Affiliation(s): St. Paul’s Hospital

Research and Scholarly Interests: Cancer, Breast pathology, General pathology, Breast, colorectal and thyroid cancer research

Clinical Interests:

hmasoudi@providencehealth.bc.ca

Short Bio
OpenClose

I graduated from Isfahan University of Medical Sciences, Iran in 1992. I moved to Canada in 2002, entered UBC pathology Residency Program in 2006 and graduated in 2009. Currently, I am working at St. Paul’s Hospital as an Anatomical pathologist.

 

Academic
OpenClose

Academic Background

  • General Pathology Residency, UBC. 2009
  • Clinical  Fellowship, Vancouver General Hospital. 2006
  • Postdoctoral Research Fellowship, GPEC, UBC. 2004
  • General Pathology Residency, Isfahan University, Iran.  2001
  • M.D. Isfahan University, Iran. 1985-1992

Special Professional Qualifications

  • FRCPC General Pathology, Royal College of Physicians and Surgeons, Canada. 2009
  • LMCC, Medical Council of Canada. 2006
  • ECFMG, United States Medical Licensing Examination. 2004
  • General Pathology Boards, Iranian Pathology Boards, Iran. 2001

Awards and Recognition

Publications

Selected Publications

Research
OpenClose

Research Interest

  • Breast pathology
  • General pathology
  • Breast, colorectal and thyroid cancer research

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

  • Teaching pathology residents
  • Teaching UBC medical students

Hutchinson, James

Hutchinson, James

MD

Academic Rank(s): Clinical Professor, Pathology and Laboratory Medicine, UBC | Medical Director – Antimicrobial Stewardship Program Staff Medical Microbiologist, VIHA

Affiliation(s): Royal Jubilee Hospital

Research and Scholarly Interests: Infectious Diseases and Immunology Microbiology

Clinical Interests:

james.hutchinson@viha.ca

Short Bio
OpenClose

 

Academic
OpenClose

Academic Background

  • FRCPC Medical Microbiology. 1993
  • University of Alberta MD. 1985
  • University of Alberta BSc (Medical Science). 1982

Awards and Recognition

  • Outstanding Overall Lecturer – “Silver Orator” award.  2010
  • Nominated (one of three) for Memorial University of Newfoundland Overall Outstanding Teacher Award.  2007
  • Outstanding 1st year teacher award. Memorial University Medical School. 2006-2007
  • Outstanding Overall Lecturer – “Silver Orator” award. 2004
  • Outstanding Overall Lecturer – “Silver Orator” award. Presented by the Medical School graduating class to the lecturer voted best during all medical school years.  2002
  • Best Original Research Paper 2001, Canadian Family Physician
  • Outstanding 1st year teacher award. Memorial University Medical School. 2000-2001
  • Outstanding 1st year teacher award. Memorial University Medical School. Presented to the teacher voted best in first year by students. 1994-95

Publications

Selected Publications

Research
OpenClose

Research Interest

I am very interested and active in the realm of Antimicrobial Stewardship and have developed special interest and abilities in population antimicrobial use measurement.

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

I was the Course Chair and sole provider of the Memorial University first year Microbiology course for 16 years. During this time microbiology was the highest rated first year course every year.

I taught in and, for the last 6 years, chaired the 2nd year Infectious Diseases course. During my time as chair the course ratings increased to be one of the highest rated courses in 2nd year.

I “pioneered” the use of on-line teaching aides at Memorial Medical School and was a very early adopter of LMS functions starting with WebCT and then D2L. I was the first to actively utilize on-line formative quizzes and helped other faculty with many functions. The last two years I conducted all exams online.
For more than 12 years I have provided all course materials in an online format and now have considerable experience and abilities with modern content management packages. I am now using WordPress and my current place in the cyberworld is infectionNet . I was delighted to see that UBC has embraced WordPress as well!

Turbin, Dmitry

Portrait photo of Dmitry Turbin

Turbin, Dmitry

MD, PhD

Academic Rank(s): Clinical Assistant Professor, Pathology and Laboratory Medicine, UBC

Affiliation(s): St. Paul’s Hospital

Research and Scholarly Interests: Translational research

Clinical Interests:

dturbin@providencehealth.bc.ca

Short Bio
OpenClose

 

Academic
OpenClose

Academic Background

  • Residency, Anatomical Pathology Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada. 2007–2012
  • Postdoctoral Fellowship Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC, Canada. 2003–2006
  • PhD (Oncology, Pathology) N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russian Federation. 1995–2000
  • Residency, Pathology Upper Health Administration, Moscow City Council, Moscow City Clinical Hospital No. 33, Moscow, Russian Federation. 1991–1993
  • Internship, Pathology City Health Administration, Moscow City Council, Moscow City Clinical Hospital No. 50, Moscow, Russian Federation. 1990–1991
  • MD Moscow Medical Stomatology Institute, Moscow, Russian Federation (now Moscow State University of Medicine and Dentistry). 1984–1990

Awards and Recognition

Publications

Selected Publications

Research
OpenClose

Research Interest

  • Translational research: evaluation of prognostic and predictive significance of expression of different biomarkers in breast carcinoma, ovarian, endometrial adenocarcinomas, soft tissue tumours, mostly using tissue microarrays; assessment of novel biomarkers in human tumours; development of algorithms of automated image analysis on histological sections.

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

  • Teaching for Anatomical and General Pathology Residents
  • Small Group Sessions and Labs for Medical Students at the UBC

Bretherick, Karla

Bretherick, Karla

PhD

Academic Rank(s): Clinical Associate Professor, Pathology and Laboratory Medicine, UBC | Laboratory Scientist at Children’s and Women’s Health Centre of British Columbia

Affiliation(s): BCCH/BCCHRI

Research and Scholarly Interests: Genetics Genomics Proteomics and Related Approaches, Human Development and Aging

Clinical Interests:

karla.bretherick@cw.bc.ca

Short Bio
OpenClose

Dr. Bretherick is a Clinical Associate Professor in the UBC Department of Pathology and Laboratory Medicine and a Molecular Genetics Fellow in the Division of Genome Diagnostics at BC Children’s and BC Women’s Hospitals. She obtained a PhD from the UBC Department of Medical Genetics in 2008 and completed 4 years of postdoctoral training at Canada’s Michael Smith Genome Sciences Centre. Her current research focuses on clinical validation and implementation of new technologies for use in diagnostic genetic testing.

 

Academic
OpenClose

Academic Background

  • Postdoctoral Fellow: Genome Sciences Centre, Vancouver, 2014
  • PhD Medical Genetics, Univerisity of British Columbia, 2008
  • BSc Cellular, Molecular, and Microbial Biology, University of Calgary, 2000

Awards and Recognition

Publications

Dr. Bretherick, Karla PUBMED

Selected Publications

Research
OpenClose

Research Interest

My research involves investigating new technologies for use in clinical genetic testing. I am also interested in identifying novel genetic variants in families with rare diseases.

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

Ballantyne, Marcia Cirino

Ballantyne, Marcia Cirino

MD MSc FRCPC

Academic Rank(s): Clinical Assistant Professor, Pathology and Laboratory Medicine, UBC | Anatomical Pathologist, Royal Inland Hospital, Kamloops

Affiliation(s): Royal Inland Hospital, Kamloops

Research and Scholarly Interests: Infectious Diseases, Dermatology

Clinical Interests:

marcia.ballantyne@interiorhealth.ca

Short Bio
OpenClose

I was born and raised in Brazil where I received my Medical Degree and completed a residency in Anatomical Pathology, a Fellowship in Dermatopathology and a Master Degree in Dermatopathology with focus in Dermatology (Brazil/ Rome, Italy). I moved to Canada and completed a second residency in Anatomical Pathology at the University of Alberta (Board certified by the Royal College of Physicians and surgeons of Canada). Next, I obtained a Specialist Certification in Dermatopathology in Frankfurt, Germany. I am also Board certified in Anatomical pathology by the American Board of Pathology.  Currently I practice Anatomical Pathology in Kamloops at the Royal Inland Hospital. My special interests are Dermatopathology and Gastrointestinal pathology. I enjoy reading, going for long walks with my dogs and travelling with my family. I am thrilled and proud to be part of the UBC faculty as a Clinical Instructor since 2012.

 

Academic
OpenClose

Academic Background

  • Executive board member (role of Secretary/ Treasurer) for the Medical Staff association (RIH-MSA) and Royal Inland Physician Association (RIHPA). 2015 to 2020 (member elected twice)
  • Board certified in Anatomical Pathology – American Board of Pathology (2014)
  • Board certified in Anatomical Pathology by The Royal College of Physicians and Surgeons of Canada (FRCPSC). June 2012
  • Board Certified in Dermatopathology, (International Committee for Dermatopathology), ICDP- UEMS – Frankfurt, Germany. December 2011
  • Residency in Anatomical Pathology, University of Alberta (UofA), Edmonton, AB Canada. July 2006 – June 2012
  • Masters Degree in Dermatology/Dermatopathology, Universidade Federal de Minas Gerais (UFMG)-Brazil and Universitta` Sacro Cuore, Rome, Italy- “Mediterranean Kaposi Sarcoma and HHV-8: Study of 60 Italian cases”. February 1998-  December 4th, 2000.
  • Fellowship in Dermatopathology, Universidade Federal de Minas Gerais (UFMG) Brazil. July 1996- November 1997
  • Board Certified in Anatomical Pathology, Brazilian Association of Pathology (SBP.org). Brazil- July 1996
  • Residency in Anatomical Pathology, Universidade Federal de Minas Gerais (UFMG)-Brazil. August 1993 – July 1996
  • MD – Doctor of Medicine, Universidade Federal do Rio Grande do Norte (UFRN). Natal, RN- Brazil. 1993

Awards and Recognition

Publications

ScienceDirect

Selected Publications

Research
OpenClose

Research Interest

Dermatology, Infectious Diseases

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

Since 2018, ongoing: I am the Lead Physician (DSSL) for the rotation for Ambulatory/ophthalmology and Dermatology Rotation at the Royal Inland Hospital.

I am also a lecturer of some topics in Pathology and I hold teaching sessions at the microscope (one to one session) with the medical students reviewing the skin biopsies they excised themselves, along with some other several filed teaching cases.

Heydarzadeh-Azar, Kamran

Portrait photo of Kamran Heydarzadeh-Azar

Heydarzadeh-Azar, Kamran

MD

Academic Rank(s): Clinical Instructor, Pathology and Laboratory Medicine, UBC

Affiliation(s): Fort St. John – Northern Health

Research and Scholarly Interests:

Clinical Interests:

kamran.azar@northernhealth.ca

Short Bio
OpenClose

I received my MD from Memorial University of Newfoundland in 1994 followed by a residency in anatomical pathology at McGill University and practiced anatomical pathology in community hospitals in Montreal area for seven years before deciding to take on the challenge of a solo pathology practice in northern British Columbia.

I have been staff pathologist (and the only pathologist) at Fort St John hospital since 2006.Surgical pathologists will know the difficulty of providing preliminary diagnoses without access to immunohistochemistry or the next door colleague to consult with. Of course, you will later have the result of immunohistochemistry and/or formal consult on the case but you will be judged on the first impression!

I enjoy teaching pathology to family medicine residents and third year UBC medical students in the integrated clerkship program here at Fort St John hospital.

 

Academic
OpenClose

Academic Background

  • McGill University, Montreal , QC, Canada. Completed residency in Anatomical Pathology. 1999
  • Memorial University of Newfoundland, St.John’s ,NL, Canada. Obtained Degree of Doctor of Medicine. 1994
  • McGill University, Montreal , QC, Canada. Obtained Degree of Bachelor of Science in Biology. 1990

Professional Qualification

  • Fellow of the Royal College of Physicians and Surgeons of Canada (Anatomical Pathology)
  • Fellow of the American Board of Pathology (Anatomical Pathology)
  • Licentiate of the Medical Council of Canada

Awards and Recognition

Publications

Selected Publications

Research
OpenClose

Research Interest

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

  • Involved in one on one and group teaching activities with medical students (Y-3 ICC) and family medicine residents at Fort St John hospital at the Rank of Clinical Instructor of Facuty of Medicine at University of British Columbia.

Lowe, Christopher

Portrait photo of Christopher Lowe

Lowe, Christopher

MD, MSc, D(ABMM), FRCPC

Academic Rank(s): Clinical Professor, Pathology and Laboratory Medicine, UBC | Virology Laboratory, St. Paul’s Hospital

Affiliation(s): St. Paul’s Hospital

Research and Scholarly Interests: Infectious Diseases and Immunology Microbiology, Hospital-acquired infections, Multidrug resistant gram negative organisms, Respiratory viruses, Hepatitis B resistance

Clinical Interests:

clowe@providencehealth.bc.ca

Short Bio
OpenClose

I was born and raised in Vancouver, and completed most of my education on the west coast. After studying Microbiology and Immunology at UBC, I completed my medical school training at UBC and my residency in Medical Microbiology at the University of Toronto. I also earned an MSc in the Department of Laboratory Medicine and Pathobiology (University of Toronto). My thesis focused on the changing epidemiology of ESBL-producing Enterobacteriaceae, and the effectiveness of admission screening for these multidrug resistant organisms. Upon completing my training, I returned to Vancouver to join the PHC Department of Pathology and Laboratory Medicine as a Medical Microbiologist and Infection Prevention and Control Physician. I am also the Program Director for the Medical Microbiology Residency Program at UBC

 

Academic
OpenClose

Academic Background

  • FRCPC, Medical Microbiology, University of Toronto, 2013
  • D(ABMM), Diplomate of the American Board of Medical Microbiology, 2013
  • MSc, Laboratory Medicine and Pathobiology, University of Toronto, 2012
  • MD, University of British Columbia, 2008
  • BSc, Microbiology and Immunology, University of British Columbia, 2004

Awards and Recognition

Publications

Link to Dr. Lowe’s PubMed Publications: https://pubmed.ncbi.nlm.nih.gov/?term=lowe+cf

Selected Publications

Research
OpenClose

Research Interest

  • Hospital-acquired infections
  • Multidrug resistant gram negative organisms
  • Respiratory viruses
  • Hepatitis B resistance

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

  • Clinical virology
  • Infection prevention and control

Hudson, James

Hudson, James

MSc, PhD

Academic Rank(s): Professor Emeritus, Pathology and Laboratory Medicine, UBC

Affiliation(s): UBC Hospital

Research and Scholarly Interests: Infectious Diseases and Immunology Microbiology, Molecular Pathology and Cell Biology

Clinical Interests:

jbhudson1984@gmail.com

Short Bio
OpenClose

James Hudson is Professor Emeritus at the University of British Columbia, Vancouver, where over the last 45 years he has carried out teaching and laboratory research on many human, animal and bacterial viruses, and the use of safe natural products to keep them under control when necessary. This has included several collaborative projects with institutes in developing countries. He has published more than 150 papers in peer – reviewed scientific journals.

 

Academic
OpenClose

Academic Background

Faculty positions:

  • Assistant Professor, University of BC. Department of Microbiology, 1968-75
  • Associate Professor, University of BC. Department of Microbiology, 1975-80
  • Professor, University of BC. Department of Pathology & Laboratory Medicine, 1980-2004
  • Professor Emeritus, 2004-present

Visiting Fellowships & Professorships:

  • University of Warwick, Department of Biological Sciences, UK, 1975-76
  • University of Western Australia, Perth, Department of Microbiology, 1986, 1990, 1992

Notable Academic Appointments:

  • Past Chair, UBC Bio-safety committee for 10 years
  • One-time Research Director, HIV/AIDS Laboratory, BC. Provincial Health Laboratory
  • One-time Co-Director UBC Viral Diagnostic Laboratory

Awards and Recognition

Publications

Selected Publications

Books (sole author)

1) Antiviral compounds from plants, by J.B. Hudson, CRC Press, 1990

2) The viruses and microbes within our bodies, by J.B. Hudson, Outskirts Press, 2013

3) Viruses in our farms: How industrial farming creates pathogenic viruses, by

JB Hudson, Friesen Press, 2014

4) The Echinacea herb story: Tradition meets modern science, by JB Hudson,

Friesen Press, 2016

Notable Book Chapters (sole author)

1) Hudson, JB. Herpesviridae, chapters 12-23 (p81-146) in Virus infections of rodents and lagomorphs. Elsevier Science, 1994

2) Hudson James, Potential of the phytomedicine Echinacea in the treatment of pulmonary infections and bronchitis. Chapter 5 in : Approaches to bronchitis, 43-52. Intech books, 2011

Journals

More than 150 publications in peer-reviewed journals (details of post-retirement articles appended).

Peer-reviewed Publications (post-retirement period, 2004-2019):

1) Beloin, N. Gbeassor, M. Akpagana, K. Hudson, J. deSoussa, K. Koumaglo, K. Arnason, JT. (2005) Ethnomedicinal uses of Momordica charanthia (Cucurbitaceae) in Togo and relation to its phytochemistry and biological activity. J. Ethnopharm. 96: 49-55

2) Hudson, J. (2005) Antiviral activities in tropical plants: limitations of existing bioassays and new research developments, in Biodiversity and Health Proc. Intl. Symp. Ottawa, 2003 ed. by Arnason et al. NRC Research Press Ottawa. 91-92

3) Vimalanathan, S. Kang, L. Treyvaud Amiguet, V. Livesey, J. Arnason, JT. Hudson, J. (2005) Echinacea purpurea aerial parts contain multiple antiviral compounds. Pharmac. Biol. 43(9): 740-745.

4) Hudson. J. Vimalanathan, S. Kang, L. Treyvaud Amiguet, V. Livesey, J. Arnason, JT (2005). Characterization of antiviral activities in Echinacea root preparations. Pharmac. Biol. 43 (9): 790-796

5) Hudson, JB. Altamirano, M (2006). The application of DNA microarrays to Ethnopharmacology research; invited review. J. Ethnopharm. 108: 2-15

6) Sharma, M. Arnason, JT. Burt, A. Hudson, JB (2006). Echinacea extracts modulate the pattern of chemokine and cytokine secretion in rhinovirus-infected and uninfected epithelial cells. Phytother Res. 20: 147-152

7) Sharma, M. Arnason, JT. Hudson,JB. (2006) Echinacea extracts modulate the production of multiple transcription factors in uninfected cells and Rhinovirus-infected cells. Phytother. Res. 20 1074-1079

8) Hudson, JB. Sharma M. Petric M. (2007) Inactivation of norovirus by ozone gas in conditions relevant to health care. J Hosp Infec 66: 40-45

9) Altamirano-Dimas,M. Hudson JB. Cochrane D. Nelson C. Arnason JT. (2007). Modulation of immune response gene expression by Echinacea extracts: results of a gene array analysis. Can J. Physiol Pharmacol. 85: 1091-1098

10) Sharma, M. Hudson, JB (2008). Ozone gas is an effective and practical anti-bacterial agent. Am J Infec Control 36: 559-563

11) Sharma, M. Schoop, R. Hudson, JB (2008). Echinacea as an anti-inflammatory agent: the influence of physiologically relevant parameters. Phytother. Res. 23: 863-867

12) Sharma M. Vohra S. Arnason JT. Hudson JB. (2008) Echinacea extracts contain significant and selective activities against human pathogenic bacteria. Pharmac. Biol. 46:111-116

13) Altamirano-Dimas,M. Sharma M. Hudson JB. (2009) Echinacea and anti-inflammatory cytokine responses: results of a gene array and protein array analysis. Pharmac. Biol. 47: 500-508

14) Vimalanathan, S. Arnason JT. Hudson JB. (2009). The anti-inflammatory activities of Echinacea extracts do not correlate with traditional marker components. Pharmac. Biol. 47: 430-435

15) S Vohra, D Adams, JB Hudson, JA Moore, S Vimalanathan, M Sharma, A Burt, E Lamonte, N Lacaze, JT Arnason, TDG Lee (2009). Selection of Natural Health Products for Clinical Trials: a preclinical template. Can J Physiol Pharmacol. 87: 371-378

16) Vimalanathan, S. Ignacimuthu,S. Hudson JB. (2009). Medicinal plants of Tamil Nadu (Southern India) are a rich source of antiviral activities. Pharmac. Biol. 47: 422-429

17) Sharma M. Anderson SA. Schoop R. Hudson JB. (2009) Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract. Antivir. Res. 87: 165-170

18) Vimalanathan S, Hudson JB (2009). Multiple inflammatory and antiviral activities in Adansonia digitata (Baobab) leaves, fruits and seeds. J. Med.Plant Res. 3: 576-582

19) Sharma M, Schoop R, Hudson JB (2009). The Efficacy of Echinacea in a 3-D Tissue Model of Human Airway Epithelium. Phytother, Res. 23: DOI: 10.1002/ptr.3051

20) Pleschka S, Stein M, Schoop R, Hudson JB (2009). Antiviral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV). Virology J. 6:197

21) Hudson JB. (2009). The use of herbal extracts in the control of influenza. J Med. Plant Res. 3 (13) 1189-1195

22) Sharma M, Anderson S, Schoop R, Hudson JB (2010). Bactericidal and anti-inflammatory properties of a standardized Echinacea extract (Echinaforce): Dual actions against respiratory bacteria. Phytomedicine. 17: 563-568.

23) Canlas J, Hudson JB, Sharma M, Nandan D (2010). Echinacea and trypanasomatid parasite interactions: Growth-inhibitory and anti-inflammatory effects. Pharmac. Biol. NPHB #448731. In Press

24) Hudson JB. Sharma M. Vimalanathan,S. (2009) Development of a practical method for using ozone gas as a virus decontaminating agent. Ozone: Science & Engineering. 31: 216-223

25) Sharma M. Hudson JB. (2009). The practical application of ozone gas as an anti-fungal (anti-mold) agent. Ozone: Science & Engineering. 31: 326-332

26) James B Hudson (2010). Review The multiple actions of the phytomedicine Echinacea in the treatment of colds and flu. Journal of Medicinal Plants Research Vol. 4(18), pp. xxx-xxx, 4 October, 2010 Available online at http://www.academicjournals.org/JMPR ISSN 1996-0875© 2010 Academic Journals

27) M. Sharma, R. Schoop and JB Hudson (2010) The Efficacy of Echinacea in a 3-D Tissue Model of Human Airway Epithelium. Phytother. Res. 24: 900–904

28) Hudson JB and Vimalanathan S, Sharma M. (2011) Review article: Immune‐modulation and Anti‐infection Properties of the Phytomedicine Echinacea. South Asian J Exp Biol; 1 (S1): 3‐11; 2011

29) James Hudson and Selvarani Vimalanathan. (2011) Review Echinacea—A Source of Potent Antivirals for Respiratory Virus Infections. Pharmaceuticals 2011, 4, 1019-1031; doi:10.3390/ph4071019. ISSN 1424-8247

30) James Hudson , Michael Kuo and Selvarani Vimalanathan. (2011) The Antimicrobial Properties of Cedar Leaf (Thuja plicata) Oil; A Safe and Efficient Decontamination Agent for Buildings. Int. J. Environ. Res. Public Health 2011, 8, 4477-4487; doi:10.3390/ijerph8124477

31) James Hudson. (2011). Potential of the Phytomedicine Echinacea in the Treatment of Pulmonary Infections and Bronchitis. Chapter Number 9. “Bronchitis”. Intech Open Access Publications.

32) M. Sharma, R. Schoop, A. Suter and J. B. Hudson. (2011). The Potential Use of Echinacea in Acne: Control of Propionibacterium acnes Growth and Inflammation. Phytother. Res. 25: 517–521 (2011)

33) James B. Hudson. (2012). Review Article Applications of the Phytomedicine Echinacea purpurea (Purple Coneflower) in Infectious Diseases. Journal of Biomedicine and Biotechnology. Volume 2012, Article ID 769896, 16 pages doi:10.1155/2012/769896

34) Selvarani Vimalanathan and James Hudson. (2012). Anti-Influenza Virus Activities of Commercial Oregano oils and their Carriers. Journal of Applied Pharmaceutical Science 02 (07); 2012: 214-218

35) Vimalanathan, Selvarani; Schoop, Roland; Hudson, James. (2013) High-potency Anti-influenza Therapy by a Combination of Echinacea purpurea fresh herb and root tinctures. Journal of Applied Pharmaceutical Science Vol. 3 (12), pp. 001-005, December, 2013. Available online at http://www.japsonline.com. DOI: 10.7324/JAPS.2013.31201 ISSN 2231-3354

36) Vimalanathan, Selvarani and Hudson, James. (2013). The Activity of Cedar Leaf oil Vapor Against Respiratory Viruses: Practical Applications. Journal of Applied Pharmaceutical Science Vol. 3 (12), pp. XXX-XXX, December, 2013. Available online at http://www.japsonline.com. DOI: 10.7324/JAPS.2013.3XXX ISSN 2231-3354

37) M. Sharma, C. Levenson, R. H. Bell, S. A. Anderson, J. B. Hudson, C. C. Collins and M. E. Cox. (2014). Suppression of Lipopolysaccharide-stimulated Cytokine/Chemokine Production in Skin Cells by Sandalwood Oils and Purified α-santalol and β-santalol. Phytother. Res. 28: 925–932 (2014) Published online 6 December 2013 in Wiley Online Library (wileyonlinelibrary.com) DOI: 10.1002/ptr.5080

38) Sharma, M., Hudson, J.B., Adomat, H., Guns, E. and Cox, M.E. (2014) In Vitro Anticancer Activity of Plant-Derived Cannabidiol on Prostate Cancer Cell Lines. Pharmacology & Pharmacy, 5, 806-820. Pharmacology & Pharmacy, 2014, 5, 806-820. http://dx.doi.org/10.4236/pp.2014.58091

39) Vimalanathan, S. Schoop, R. Suter, A. Hudson, J (2017). Prevention of influenza virus-induced bacterial superinfection by standardized Echinacea purpurea, via regulation of surface receptor expression in human bronchial epithelial cells. Virus Research 233 (2017) 51–59

40) Hudson,JB Vimalanathan, S. 2017. The phytomedicine Echinacea purpurea contains light-dependent and light-independent antiviral activities. J. Innovations in Pharmaceutical and Biological Sciences (JIPBS). Vol 4 (3) 109-113

41) Hudson, James B, 2019, Review article: Cedar leaf oil vapor in buildings and forests: Health benefits & mechanisms. JIPBS Vol. 6 (4), 33-41, Oct-Dec

Research
OpenClose

Research Interest

  • Viruses of humans, animals, fish and invertebrates (>50 years experience)
  • Naturally occurring anti-viral and anti-microbial substances (>30 years experience)
  • Molecular approaches to elucidating mechanisms of action of herbal medicines
  • Several collaborative projects with Institutes in developing countries in Africa and Asia

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

I have trained several post-doctoral Fellows, approximately 20 graduate students (Ph.D. and M.Sc. levels), and numerous honors undergraduate students.

Karunakaran, Karuna

Portrait photo of Karuna Karunakaran

Karunakaran, Karuna

MSc, PhD

Academic Rank(s): Clinical Assistant Professor, Pathology and Laboratory Medicine, UBC | Senior Scientist, BC Centre for Disease Control, PHSA

Affiliation(s): BC Centre for Disease Control

Research and Scholarly Interests: Genetics genomics proteomics and related approaches, Infectious Diseases and Immunology Microbiology

Clinical Interests:

<ponniahk@mail.ubc.ca

Short Bio
OpenClose

Dr Karunakaran’s present research interest at the BC Centre for Disease Control (BCCDC) involves identifying vaccine targets for Chlamydia trachomatis using a novel dendritic cell-based immunoproteomic approach.

This approach involves identifying Chlamydia-derived peptides binding to MHC molecules on the surface of dendritic cells by tandem mass spectroscopy to allow genomic information to guide the delineation of the complete immune proteome of Chlamydia. This methodology has lead to the identification of many novel vaccine candidates that can be further developed into a vaccine against human Chlamydia infection.

His previous research work at BCCDC involved molecular approaches to study chlamydial pathogenesis. He undertook detailed bioinformatic, genetic and immunologic studies of the three chlamydial groEL genes and proteins to determine if this could shed light on their role(s) in chlamydial pathogenesis.

Dr. Karunakaran also investigated the roles played by the Chlamydia pneumoniae bacteriophage PhiCpn1 in relation to C. pneumoniae pathogenesis of atherosclerosis. In this study, he developed methodologies to detect the presence of the phage in clinical isolates of C. pneumoniae and of phage-related antibodies in sera from humans to further investigate the relationship between C. pneumoniae infection and vascular disease.

At BCCDC, he also developed a serologic test to quantify humoral immune response to the Human Papilloma Viruses. The aim of this study was to implement and validate a serologic test to quantify the subtype specific humoral immune response to the HPV16 and HPV18 based on detection of neutralizing antibody to the respective subtypes. This test is now being used at BCCDC to ascertain the level of type specific neutralizing antibody after HPV vaccination and to potentially correlate this with protective vaccine efficacy.

During the SARS out break in 2002, Dr. Karunakaran was actively involved in SARS research along with other scientists at BCCDC to monitor and control the spread of the SARS virus . He developed serological assays to detect SARS induced antibodies in humans and  involved in the testing of different SARS vaccine candidates both in mouse and ferret models as part of SARS Accelerated Vaccine Initiative.

During his post-doctoral work with Dr. Julian Davies at the Department of Microbiology & Immunology at University of British Columbia he studied the development of multiple antibiotic resistance in mycobacteria. His study suggested that the generation of multiply drug resistant strains by successive mutations may be a more complex genetic phenomenon than suspected.

Dr. Karunakaran’s PhD work on Molecular Biology involved characterization of temperature sensitive and copy number mutants of the broad-host-range plasmid RK2 in order to exploit its biology in different gram negative bacteria. The knowledge he generated through this study helped to understand RK2 biology in general as well as to construct many RK2 plasmid based expression vectors.

 

Academic
OpenClose

Academic Background

  • PhD, Norwegian University of Science and Technology, Molecular Biology.  1997
  • MSc, University of Trondheim, Norway, Biochemistry.  1992
  • BSc, University of Jaffna, Sri Lanka, Biology.  1992

Awards and Recognition

  • Award for Teaching Excellence, Faculty of Dentistry, UBC, Vancouver, BC. 2006

Publications

Selected Publications

  • Krajden, M., Cook, D., Yu, A., Chow, R., Su, Q., Mei, W., McNeil, S., Money, D., Dionne, M., Palefsky, J.M., Karunakaran, K.P., Kollmann, T., Ogilvie, G., and Petric, M., Dobson, S. 2014. Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial. Vaccine. 32:624-30. PubMed PMID: 24055350.
  • Yu H, Karunakaran KP, Jiang X, Brunham RC. 2014. Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital infection in three strains of mice. Vaccine. 32:4672-80. PubMed PMID: 24992718.
  • Yu H, Karunakaran KP, Jiang X, Shen C, Andersen P, Brunham RC. Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice. Infect Immun. 2012 Apr;80(4):1510-8. doi: 10.1128/IAI.06338-11.
  • Johnson RM, Yu H, Kerr MS, Slaven JE, Karunakaran KP, Brunham RC. PmpG303-311, a protective vaccine epitope that elicits persistent cellular immune responses in Chlamydia muridarum-immune mice. Infect Immun. 2012 Jun;80(6):2204-11.
  • Yu H, Karunakaran KP, Kelly I, Shen C, Jiang X, Foster LJ, Brunham RC. Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: correlation with MHC class II peptide presentation and multifunctional Th1 cells. J Immunol. 2011 Mar 15;186(6):3615-21.
  • Krajden M, Cook D, Yu A, Chow R, Mei W, McNeil S, Money D, Dionne M, Karunakaran KP, Palefsky JM, Dobson S, Ogilvie G, Petric M. Human papillomavirus 16 (HPV 16) and HPV 18 antibody responses measured by pseudovirus neutralization and competitive Luminex assays in a two- versus three-dose HPV vaccine trial. Clin Vaccine Immunol. 2011 Mar;18(3):418-23.
  • Karunakaran KP, Yu H, Foster LJ, Brunham RC. Development of a Chlamydia trachomatis T cell Vaccine. Hum Vaccin. 2010 Aug;6(8):676-80.
  • Yu H, Jiang X, Shen C, Karunakaran KP, Jiang J, Rosin NL, Brunham RC. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells. Infect Immun. 2010 May;78(5):2272-82.
  • Jiang X, Shen C, Yu H, Karunakaran KP, Brunham RC. Differences in innate immune responses correlate with differences in murine susceptibility to Chlamydia muridarum pulmonary infection. Immunology. 2010 Apr;129(4):556-66.
  • Krajden M, Karunakaran K, So S, Palefsky JM, Sharma R, Cook D, Yu A, Chow R, Dobson S, Ogilvie GS, Petric M. Prevalence of human papillomavirus 16 and 18 neutralizing antibodies in prenatal women in British Columbia. Clin Vaccine Immunol. 2009 Dec;16(12):1840-3.
Research
OpenClose

Research Interest

Dr Karuna Karunakaran’s present research at UBC CDC involves identifying vaccine targets for Chlamydia trachomatis. The overall objective of this project is to validate a novel dendritic cell-based immunoproteomics technology as a means of identifying novel T cell antigen candidates for the development of efficacious vaccines for important intracellular pathogens such as C. trachomatis. Dr Karunakaran’s past work at UBCCDC involved investigating the roles played by the C. pneumoniae bacteriophage phiCpn1 in relation to C. pneumoniae pathogenesis of atherosclerosis. His post-doctoral work with Dr. Julian Davies at the Department of Microbiology & Immunology at UBC involved studies on the mechanisms of antibiotic resistance in mycobacteria. In this work he studied the development of multiple antibiotic resistance in mycobacteria. His Ph.D. work in Molecular Microbiology involved characterization of temperature sensitive and copy number mutants of the broad-host-range plasmid RK2 in order to exploit its biology in different gram negative bacteria.

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

Ng, Tony

Portrait photo of Tony Ng

Ng, Tony

MD/PhD FRCPC

Academic Rank(s): Clinical Associate Professor, Pathology and Laboratory Medicine, UBC | Staff Pathologist, Vancouver General Hospital

Affiliation(s): VGH/VCHRI

Research and Scholarly Interests: Cancer, Genetics genomics proteomics and related approaches

Clinical Interests:

Tony.Ng@vch.ca

Short Bio
OpenClose

Dr. Tony Ng is a head and neck pathologist and sarcoma pathologist at Vancouver General Hospital, as well as a clinical associate professor in the Department of Pathology and Laboratory Medicine at the University of British Columbia.

 

Academic
OpenClose

Academic Background

  • PhD, Pathology and Laboratory Medicine, The University of British Columbia. 2014
  • Residency, Anatomical Pathology, The University of British Columbia. 2012
  • MD, The University of British Columbia. 2004

Awards and Recognition

Publications

Selected Publications

  • Sweeney R.T., McClary A.C., Myers B.R., Biscocho J., Neahring L., Kwei K.A., Qu K., Gong X., Ng T., Jones C.D., Varma S., Odegaard J.I., Sugiyama T., Koyota S., Rubin B.P., Troxell M.L., Pelham R.J., Zehnder J.L., Beachy P.A., Pollack J.R., West R.B. Identification of recurrent SMO and BRAF mutations in ameloblastomas. Nat Genet. 2014 Jul;46(7):722-5.
  • Ng T. L., Leprivier G., Robertson M.D., Martin M.J., Laderoute K.R., Davicioni E., Triche T.J., Sorensen P.H. The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis. Cell Death Diff. 2012 Mar; 19(3):501-10. Journal article).
  • Lange AP., Moloney G., Arino M., Ng T., McCarthy J.M., White VA, Holland S.P. Enzyme-assisted deep anterior lamellar keratoplasty-a new method of lamellar dissection-a wetlab-based pilot study. Cornea 2012 Mar 29 [Epub ahead of print] Journal article).
  • Potratz J.C., Saunders D.N., Wai D.H., Ng T.L., McKinney S.E., Carboni J.M., Gottardis M.M., Triche TJ., Jurgens H., Pollak M.N., Aparicio SA, Sorensen P.H. Synthetic Lethality Screens Reveal RPS6 and MST1 R as Modifiers of Insulinlike Growth Factor-1 Receptor Inhibitor Activity in Childhood Sarcomas. Cancer Res. 2010 Nov 1; 70(21 ):8770-81. Journal article).
  • Strauss S.J., Ng T., Mendoza-Naranjo A, Whelan J., Sorensen P.H. Understanding Micrometastatic Disease and Anoikis Resistance in Ewing Family of Tumors and Osteosarcoma. Oncologist. 2010; 15(6):627-35. Journal article).
  • Evdokimova V., Tognon C., Ng T., Sorensen P.H. Reduced proliferation and enhanced migration: two sides of the same coin? Molecular mechanisms of metastatic progression by YB-1. Cell Cycle. 2009 Sep 15;8(18):2901-6. Journal article).
  • Viswanathan S.R., Powers J.T., Einhorn W., Hoshida Y., Ng T.L., Toffanin S., O’Sullivan M., Lu J., Phillips L.A, Lockhart V.L., Shah S.P., Tanwar P.S., Mermel C.H., Beroukhim R., Azam M., Teixeira J., Meyerson M., Hughes T.P., Llovet J.M., Radich J., Mullighan C.G., Golub T.R., Sorensen P.H., Daley G.a. Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet. 2009 Jul;41 (7):843-8. Journal article).
  • Evdokimova V., Tognon C., Ng T., Ruzanov P., Melnyk N., Fink D., Sorokin A, Ovchinnikov L.P., Davicioni E., Triche T.J., Sorensen P.H. Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. Cancer Cell. 2009 May 5;15(5):402-15. Uournal article).
  • Chuo J.Y., Dolman P.J., Ng T.L., Buffam F.v., White VA Clinical and histopathologic review of 18 explanted porous polyethylene orbital implants. Ophthalmology. 2009 Feb; 116(2):349-54. Uournal article).
  • Ng T.L., O’Sullivan M.J., Pallen C.J., Hayes M., Clarkson P.W., Winstanley M., Sorensen P.H., Nielsen T.O., Horsman D.E. Ewing Sarcoma with Novel Translocation t(2; 16) Producing an In-Frame Fusion of FUS and FEV. J Mol Diagn. 2007 Sep;9(4):459-63. Journal article).
Research
OpenClose

Research Interest

Cancer

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

Teaching the head and neck surgery residents and the oral pathology residents

Wang, Li

Wang, Li

MD, MSc, FRCPC

Academic Rank(s): Clinical Professor, Pathology and Laboratory Medicine, UBC | Medical Biochemist, BC Children’s Hospital

Affiliation(s): BCCH/BCCHRI

Research and Scholarly Interests: Endocrinology, Metabolism & Nutrition, Genetics genomics proteomics and related approaches

Clinical Interests:

li.wang@cw.bc.ca

Short Bio
OpenClose

Dr. Wang graduated from China Medical University with a MD and Master’s degree. She then completed her training in Internal Medicine and Endocrinology and worked as a staff endocrinologist at the Shengjing Hospital of China Medical University. Her strong interests in both clinical service and laboratory medicine directed her to choose the Medical Biochemistry residency training program at McMaster University. Dr. Wang received her fellowship in the Royal College of Physicians and Surgeons in 2013 and joined Children’s & Women’s Health Centre of BC as a Medical Biochemist.

On clinical service, Dr. Wang provides consultations to clinicians on test selections, interpretation of test results and setting up new laboratory tests if clinically indicated. Her research interests focus on developing new laboratory markers for pediatric and obstetrical diseases. She is also actively involved in training medical biochemistry residents, general pathology residents, endocrinology fellows and teaching in the UBC Bachelor of Medical Laboratory Science Program.

 

Academic
OpenClose

Academic Background

  • MSc, China Medical University, Liaoning, China. 1997
  • MD, China Medical University, Liaoning, China. 1994

Professional Qualifications

  • FRCPC in Medical Biochemistry. December 2013
  • CPSBC: License to practice in British Columbia, Canada. May 2013-present
  • Licentiate of the Medical Council of Canada. December 2007

Awards and Recognition

  • Clinical Translational Research Seed Grant, Child & Family Research Institute (2014-2015)
  • First place for oral presentation, Canadian Association of Medical Biochemists (CAMB) annual meeting (11/2012)
  • First place for best case report/series presentation, Department of Pathology & Molecular Medicine, Resident Research Day, McMaster University (5/2012)
  • Physicians’ Services Incorporated (PSI) Foundation Resident Prize (7/2011)
  • Second place for best paper presentation, Department of Pathology & Molecular Medicine, Resident Research Day, McMaster University (5/2011)
  • Second place for best paper presentation, Department of Pathology & Molecular Medicine, Resident Research Day, McMaster University (5/2011)
  • Quality Assurance Award from postgraduate office of McMaster University (7/2010)
  • First place for best paper presentation, Department of Pathology & Molecular Medicine, Resident Research Day, McMaster University (5/2010)

Publications

Selected Publications

Research
OpenClose

Research Interest

  • Preeclampsia
  • Pediatric toxicology
  • Endocrine disorders
  • Method development
  • Point of care testing

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

  • Evidence-based laboratory medicine

Wong, Titus

Wong, Titus

BSc(Pharm), MD, MHSc (Epidemiology), FRCPC

Academic Rank(s): Clinical Assistant Professor, Dept of Pathology & Laboratory Medicine, UBC, Medical Microbiologist, BCCDC Public Health Lab, Medical Director for Infection Prevention and Control and Community Health

Affiliation(s): PHSA/BCCDC

Research and Scholarly Interests: antimicrobial copper in healthcare, ultraviolet disinfection, clean air strategies

titus.wong@phsa.ca

Short Bio
OpenClose

Titus Wong was born and raised in Vancouver, BC. He completed his MD and Medical Microbiology residency at the University of British Columbia, and earned a Masters in Health Science (Clinical Epidemiology) from the UBC School of Population and Public Health. He joined the Department of Pathology and Laboratory Medicine at Vancouver General Hospital in 2012. He currently serves as an executive medical director in Medical Affairs at Provincial Health Services Authority, overseeing a portfolio that includes Infection Prevention and Control, Medical Staff Safety, Medical Staff Wellbeing, Antimicrobial Stewardship and Medical Assistance in Death (MAiD) & Advanced Care Planning (ACP). Titus is also the provincial medical director of BC’s Provincial Infection Control Network (PICNet), as well as a medical microbiologist at the BC Centre for Disease Control (BCCDC) Public Health laboratory, and the BCCDC Medical Director for IPAC and Community Health. He co-created and is the medical director for the Vancouver Coastal Health/ BC Ministry of Health Personal Protective Equipment Testing Laboratory. Titus has research interests in the testing and clinical application of environmental infection control strategies, and the clinical impact of rapid microbiology/infectious diseases diagnostic technologies. Titus contributes to several provincial and national groups including CMPT, CNISP, AMMI-Canada, PICNET, and Doctors of BC.

 

Academic
OpenClose

Academic Background

  • MHSc, Master of Health Science, Clinical Epidemiology, University of British Columbia, 2014
  • Fellow of the Royal College of Physicians and Surgeons of Canada (FRCPC), Medical Microbiology, 2012
  • Medical Microbiology Residency, University of British Columbia, 2012
  • MD, Doctor of Medicine, University of British Columbia, 2007
  • BSc(Pharm), Bachelor of Sciences in Pharmacy, University of British Columbia, 2003

Awards and Recognition

Publications

Publications

Research
OpenClose

Research Interest

  • Control and prevention of Hospital-Acquired Infections
  • Environmental Infection Control
  • Clinical impact of rapid microbiology/infectious diseases diagnostic technologies
  • Surveillance of infectious diseases
  • Antimicrobial copper in healthcare
  • Ultraviolet disinfection
  • Clean air strategies

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

As a staff physician at Vancouver General Hospital, Titus supervises medical students, residents and fellows as they rotate through the Medical Microbiology and Infection Control services.

  • Course Co-director, Pathology 722: Medical Microbiology and Infection Control
  • Lecturer, UBC MEDD 411, MD undergraduate program
  • Lecturer, UBC MEDD 412, MD undergraduate program
  • Lecturer, UBC MEDD 422, MD undergraduate program
  • Lecturer, UBC Infectious Diseases and Medical Microbiology Academic Half Day
  • Lecturer, UBC Anatomic Pathology Academic Half Day
  • Lecturer, UBC Internal Medicine Bootcamp

Lockwood, William

Lockwood, William

PhD

Academic Rank(s): Professor, Pathology and Laboratory Medicine, UBC | Senior Scientist, Integrative Oncology, BC Cancer Agency

Affiliation(s): BCCA/BCCRC

Research and Scholarly Interests: Cancer, Genetics genomics proteomics and related approaches

Clinical Interests:

wlockwood@bccrc.ca

Short Bio
OpenClose

Dr. Lockwood received his BSc. in Microbiology and Immunology from the University of British Columbia (2004) and completed his Ph.D. in Pathology and Laboratory Medicine (2009) at the same university, training with the lung cancer research group at BC Cancer Research Centre where he aimed to characterize the genetic mechanisms underlying development of different lung cancer subtypes. He pursued postdoctoral studies as a CIHR Jean-Francois St. Dennis Fellow in Cancer Research in the laboratory of Nobel laureate Dr. Harold Varmus, first at Memorial Sloan-Kettering Cancer Center, New York, and later at the National Human Genome Research Institute in Bethesda, MD. There, he focused on utilizing mouse models of lung cancer to study mechanism of lung cancer initiation, progression and response to therapy and identifying novel therapeutics for lung cancer treatment. Dr. Lockwood returned to the BC Cancer Research Institute to begin his own research group in 2014 with a focus on understanding lung cancer biology using integrative genomics approaches. His lab has specific interest in dissecting genes and signalling pathways that drive lung cancer development and targeted therapy resistance, using both model systems and genomic data from patients for this purpose. He is the recent recipient of the Michael Smith Foundation for Health Research Scholar and the International Association for the Study of Lung Cancer Young Investigator awards.

 

Academic
OpenClose

Academic Background

  • Post-Doctoral Fellow (Cancer Genetics), with Harold Varmus, National Human Genome Research Institute, 2010-2014
  • Post-Doctoral Fellow (Cancer Biology and Genetics), with Harold Varmus, Memorial Sloan-Kettering Cancer Center, 2009-2010
  • PhD (Pathology and Laboratory Medicine), University of British Columbia, 2009
  • BSc (Microbiology and Immunology), University of British Columbia, 2004

Awards and Recognition

  • Michael Smith Foundation for Health Research Scholar Award. 2014-2019
  • CIHR Jean-Francois St. Dennis Fellowship in Cancer Research. 2010-2013
  • Postdoctoral Fellowship. Canadian Institutes of Health Research. 2010-2013
  • Research Trainee Award (Senior). Michael Smith Fdn Health Research. 2008-2010
  • International Association for the Study of Lung Cancer Young Investigator Award. 2009
  • BCCA Betty Rice Memorial Award for Lung Cancer Research. 2008
  • Canadian Graduate Scholarship (Doctoral). NSERC Canada. 2006-2008
  • Research Trainee Award (Junior). Michael Smith Fdn Health Research. 2006-2008
  • Postgraduate Scholarship. NSERC Canada. 2004-2006

Publications

Link to Dr. Lockwood’s Google Scholar Profile: https://scholar.google.ca/citations?user=He7XywkAAAAJ&hl=en .

Selected Publications

  • Johnson F, Ferrarone J, Liu A, Brandstädter C, Munuganti R, Farnsworth D, Lu D, Luu J, Sihota T, Jansen S, Nagelberg A, Shi R, Forcina GC, Zhang X, Cheng GSW, Spencer Miko SE; de Rappard- Yuswack G, Sorensen PH, Dixon SJ, Guha U, Becker K, Djaballah H, Somwar R, Varmus H, Morin GB, Lockwood WW. (2022). Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells. Cell Rep. 2022 Feb 8;38(6):110343. SA.
  • Lu D, Nagelberg A, Chow J, Chen YT, Michalchuk Q, Somwar R, Lockwood WW (2022) MET exon 14 splice-site mutations preferentially activate KRAS signaling to drive tumorigenesis. Cancers. In Press.
  • Calder J, Luu J, Nagelberg A, Lu D, Lockwood WW (2021) Resistance to BET inhibitors in lung adenocarcinoma is mediated by caesin kinase phosphoylation of BRD4. Oncogenesis. 10(3): 27. SA.
  • Inoue Y, Nikolic A, Farnsworth D, Liu A, Ladanyi M, Somwar R, Gallo M, Lockwood WW. (2021). Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer. eLife. 10: e66524. SA.
  • Melese ES, Franks E, Cederberg RA, Harbourne BT, Shi R, Wadsworth BJ, Collier JL, Halvorsen EC, Johnson F, Luu J, Oh MH, Lam V, Krystal G, Hoover SB, Raffeld M, Simpson RM, Unni AM, Lam WL, Lam S, Abraham N, Bennewith KL*, Lockwood WW* (2022) CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development, OncoImmunology, 11:1. *Co-Senior Author.
  • Deng H, Liu H, De Silva T, Xue Z, Mohamud Y, Qu J, Zhang J, Jia W, Lockwood WW*, Luo H* (2019) Coxsackievirus Type B3 is A Potent Oncolytic Virus Against KRAS-Mutant Lung Adenocarcinoma. Molecular Therapy – Oncolytics. 4:266-278 [*co-senior author] SA.
  • O’Farrell H, Harbourne B, Kurlawala Z, Inoue Y, Nagelberg A, Martinez V, Oh MH, Coe B, Thu K, Lam S, Lam W, Unni AM, Beverly L, Lockwood WW (2019) Integrative genomic analysis identifies GGA2 as a cooperative driver of EGFR mediated lung tumorigenesis. Journal of Thoracic Oncology. 14(4):656-671. SA.
Research
OpenClose

Research Interest

  • Lung cancer
  • Genomics
  • Drug Discovery
  • Mouse Models
  • Cell Lineage
  • Oncogene Signaling
  • Immune Response

Research Program

Lung cancer is the leading cause of cancer mortality worldwide, suffering from a late stage of disease at the time of diagnosis and a paucity of effective therapeutic strategies to treat advanced tumours. However, with our increasing understanding of lung cancer biology has come the advent of targeted therapies to combat this devastating disease. These therapies target mutated components of key cellular pathways on which tumours have become dependent on for survival, yielding drastic initial response rates without the major side effects of traditional chemotherapies. Despite these successes two major problems remain: first, the majority of lung cancer patients have tumours without mutations in targetable genes and; second, all patients eventually develop resistance to treatment with these targeted agents. In addition, since lung tumours commonly have hundreds of mutated genes, it is difficult to pinpoint those that are responsible for tumour growth and resistance to therapy, creating a clear bottleneck in the translation of laboratory findings to a clinical setting.

My lab utilizes an integrative strategy to address these issues. Through analysis of the genomic profiles of human lung tumours, we aim to identify novel genes and pathways that are altered during lung cancer development. Furthermore, by combining this information with the characterization of mice genetically engineered to develop lung tumours, we attempt to elucidate the key genes driving lung cancer initiation, progression and response to therapy. Lastly, by screening libraries of chemical compounds across lung cancer cells, we aim to characterize novel inhibitors of these identified genes and their corresponding pathways that show promise for use as targeted therapies. Together, this work will further our understanding of lung cancer biology and create insight toward the development of new approaches to diagnose and treat patients suffering from this disease.

Clinical Service

Current Projects In My Lab Include

  • Directed Studies/Co-Op Students
  • MSc and PhD Students
  • Postdoctoral Fellows
Teaching
OpenClose

Teaching Interest

  • Scientific communication and outreach
  • Cancer biology and treatment
  • Mechanisms and models of cancer

Salina, Davide

Portrait photo of Davide Salina

Salina, Davide

MD, PhD, FRCPC

Academic Rank(s): Clinical Associate Professor, Pathology and Laboratory Medicine, UBC

Affiliation(s): Royal Jubilee Hospital

Research and Scholarly Interests: Cancer, Molecular Pathology and Cell Biology

Clinical Interests:

davide.salina@viha.ca

Short Bio
OpenClose

 

Academic
OpenClose

Academic Background

  • Anatomic Pathology Residency, University of Calgary. 2008-2012
  • Cytopathology Fellowship, MD Anderson Cancer Center, Houston Texas
  • MD, University of Calgary (Medical Science). 2003/08 – 2006/05
  • PhD, University of Calgary and University of Florida (Cancer Cell Biology). 1998/09 – 2003/08
  • BSc(honours), University of Calgary (Biochemistry). 1993/08 – 1998/03

Professional Qualifications:

  • College of Physicians and Surgeons of Canada in Anatomic Pathology, 2012
  • Diplomate of American Board of Pathology in Anatomic Pathology 2012
  • Specialist in American Board of Pathology in Cytopathology, MD Anderson Cancer Center 2013
  • Thin Prep Pap Test Certification from Cytyc Corp 2012

Awards and Recognition

  • Donald W. Penner Award (National Award from Canadian Association of Pathology annual conference in Vancouver, British Columbia for best proffered paper presentation). July 2011
  • Canadian Chairs Award in Experimental Pathology (National Award from Canadian Association of Pathology annual conference in Montreal, Quebec, July 2010). July 2010
  • Governor General Gold Medal (The Chancellery of Honors, Office of the Secretary to the Governor General, Ottawa Canada). November 2004
  • Izaak Walton Killam Memorial Scholarship (University of Calgary). April 2003
  • Research Innovation Award (University of Calgary). January 2003
  • NSERC Natural Science and Engineering Research Council of Canada Post Graduate Scholarship (PGSB). Sept 01, 2001- Aug 31, 2003
  • Alberta Heritage Foundation for Medical Research, Graduate studentship (AHFMR). Jul 01, 2001- Jun 31, 2006

Publications

Selected Publications

  • Proximal epithelioid sarcoma after a history of malignant melanoma: a diagnostic challenge. Wang G, van der Westhuizen N, Hyrcza M, Pringle K, Salina D. Cytopathology. 2016 May 18. doi: 10.1111/cyt.12341.
  • Pulmonary artery intimal sarcoma diagnosed using endobronchial ultrasound-guided transbronchial needle aspiration. Caraway NP, Salina D, Deavers MT, Morice R, Landon G. Cytojournal. 2015 Feb 18;12:3. doi: 10.4103/1742-6413.151667.
  • Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo. Yipp BG, Petri B, Salina D, Jenne CN, Scott BN, Zbytnuik LD, Pittman K, Asaduzzaman M, Wu K, Meijndert HC, Malawista SE, de Boisfleury Chevance A, Zhang K, Conly J, Kubes P. Nat Med. 2012 Sep;18(9):1386-93.
  • A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus. Pilsczek FH, Salina D, Poon KK, Fahey C, Yipp BG, Sibley CD, Robbins SM, Green FH, Surette MG, Sugai M, Bowden MG, Hussain M, Zhang K, Kubes P. J Immunol. 2010 Dec 15;185(12):7413-25.
  • Aspects of nuclear envelope dynamics in mitotic cells. Burke B, Shanahan C, Salina D, Crisp M. Novartis Found Symp. 2005;264:22-30; discussion 30-4, 227-30. Review.
  • Nuclear envelope dynamics during mitosis. Burke B, Crisp M, Salina D. Symp Soc Exp Biol. 2004;(56):205-16. Review.
  • Nup358 integrates nuclear envelope breakdown with kinetochore assembly. Salina D, Enarson P, Rattner JB, Burke B. J Cell Biol. 2003 Sep 15;162(6):991-1001.
  • Cytoplasmic dynein as a facilitator of nuclear envelope breakdown. Salina D, Bodoor K, Eckley DM, Schroer TA, Rattner JB, Burke B. Cell. 2002 Jan 11;108(1):97-107.
  • Function and assembly of nuclear pore complex proteins. Bodoor K, Shaikh S, Enarson P, Chowdhury S, Salina D, Raharjo WH, Burke B. Biochem Cell Biol. 1999;77(4):321-9. Review.
  • Sequential recruitment of NPC proteins to the nuclear periphery at the end of mitosis. Bodoor K, Shaikh S, Salina D, Raharjo WH, Bastos R, Lohka M, Burke B. J Cell Sci. 1999 Jul;112 ( Pt 13):2253-64.
Research
OpenClose

Research Interest

  • Genitourinary malignancies and inflammation in collaboration with BCCA Deeley Research Center
  • Rapid on site assessment/image guided/ fine needle aspiration cytopathology of non gynecological malignancies

Clinical Service

Current Projects In My Lab Include

  • Defining immune signatures in genitourinary cancers and their association with outcome, VIHA collaborative grant project with Dr. Julian Lum at BC Cancer Agency, UBC Pathology Resident Basile Tessier-Cloutier
Teaching
OpenClose

Teaching Interest

  • University of British Columbia Island Medical Program Anatomic Pathology
  • Pathology electives, medical student or resident collaborative research projects welcome in both non gynecological cytopathology or surgical patholog

Wang, Bing

Wang, Bing

MD, PHD, FRCPC, DABMM

Academic Rank(s): Clinical Assistant Professor, Pathology and Laboratory Medicine, UBC

Affiliation(s): Kelowna General Hospital

Research and Scholarly Interests: Genetics genomics proteomics and related approaches, Infectious Diseases and Immunology Microbiology

Clinical Interests:

bing.wang@interiorhealth.ca

Short Bio
OpenClose

I am excited to join the Department of Pathology and Laboratory Medicine as a medical microbiologist. I received my MD and PhD from Sichuan University, China, and completed residency in University of Ottawa, Ontario. I am currently working in the Interior Health microbiology service and Infection Control based at Kelowna General Hospital.

 

Academic
OpenClose

Academic Background

Awards and Recognition

Publications

Selected Publications

Research
OpenClose

Research Interest

My research interests include utilization of advanced technology to improve the quality of microbiology service and yeast susceptibility.

Clinical Service

Current Projects In My Lab Include

Teaching
OpenClose

Teaching Interest

I am involved in teaching medical student and supervising student research projects.

Priatel, John

Portrait photo of John Priatel

Priatel, John

PhD

Academic Rank(s): Assistant Professor, Pathology and Laboratory Medicine, UBC

Affiliation(s): BCCHRI

Research and Scholarly Interests: Blood research, Infectious Diseases and Immunology Microbiology, Autoimmunity, Primary Immunodeficiency Diseases, Immune Regulation, T cell function

Clinical Interests:

jpriatel@mail.ubc.ca

Short Bio
OpenClose

 

Academic
OpenClose

Academic Background

  • PhD, University of British Columbia, Biomedical Research Centre ) then moved with advisor to Howard Hughes Medical Institute, University of California San Diego, (Genetics Program). 1990 – 1997
  • BSc, University of British Columbia, (Microbiology & Immunology). 1985 – 1989

Awards and Recognition

Publications

http://www.ncbi.nlm.nih.gov/pubmed/?term=priatel+JJ

Selected Publications

Research
OpenClose

Research Interest

  • Autoimmunity
  • Primary Immunodeficiency Diseases
  • Immune Regulation
  • T cell function

Summary

T cells form an integral part of our immune system and are essential to fight off most infections. To perform these roles, T cells must be able to differentiate between a variety of different antigens (defined as molecules that elicit immune responses). Excessive T cell responses towards harmless-(eg. dietary) antigens may result in dangerous food allergies while T cell attack against self-antigens (healthy cells or tissue) may cause T cell-mediated self-destruction (autoimmune disease). Conversely, dampened T cell responses against infected or malignant cells may lead to immunodeficiency (associated with chronic or life-threatening infections) or expansion of cancerous cells (tumour growth). By adding to the knowledge of how T cells can be turned “on” or “off”, we hope to uncover new therapies for human diseases related to allergy, autoimmunity, immunodeficiency and cancer.

Clinical Service

Current Projects In My Lab Include

X-linked lymphoproliferative disease
Epstein-Barr virus (EBV) is a γ-herpesvirus that infects more than 90% of the adult population, often resulting in subclinical or self-limiting infections. However, EBV poses serious health consequences for immunocompromised individuals, such as patients undergoing transplant or chemotherapeutic regimens, and is strongly associated with an expanding list of human cancers. To gain insight into immunity against EBV, we are studying a rare congenital immunodeficiency defined by exquisite sensitivity to EBV but not other pathogens called X-linked lymphoproliferative disease, a syndrome caused by mutations in the SH2D1A gene that encodes SLAM-associated protein (SAP). The inability of boys with XLP to control EBV infection results in fulminant, often fatal, infectious mononucleosis, massive expansions of EBV-infected B cells and malignant B cell lymphomas. To uncover how SAP loss contributes to susceptibility to EBV, we are investigating the role of SAP and SLAM receptors in the regulation of B cell-driven immune responses.

Immunoregulation of autoreactive T cells
A breakdown of immunological tolerance can result in autoreactive T cells causing organ-specific (eg. type 1 diabetes) or system-wide autoimmune diseases (systemic lupus erythematosus). Multiple mechanisms collaborate to maintain T cell tolerance and curtail potentially lethal consequences stemming from one’s own immune system attacking normal, healthy tissues and cells. Although many autoreactive T cells are programmed to die during their development in the thymus, some escape into the periphery and are thought to be restrained by a tolerance mechanism called anergy (non-antigen responsive state). The preservation of autoreactive T cells through anergy may result in dire autoimmune consequences if their function could be reawakened. Conversely, the reinvigoration of anergized T cells could be of benefit for promoting anti-cancer immune responses. My research program utilizes both in vitro cellular immunology assays and mouse model systems to study the regulation of autoreactive T cells and delineate the roles of specific genes or signalling pathways in governing their function.

Teaching
OpenClose

Teaching Interest

I have devoted myself to a career in science because I believe advancing the human condition and understanding the bases of human disease is essential for improving treatments. My enthusiasm for science has developed from a deep admiration for novel means to unlock life’s mysteries using critical thinking and scientific reasoning. Teaching is very important to me as it provides me a chance to positively affect students and perhaps, make my greatest impact on society. In contrast to the classic-style of professor lecturing/student note taking, I think that science classes need to be interactive so that one can receive feedback on how well students comprehending classroom lectures. I aspire to generate subject interest by adopting a number of strategies to engage students in the subject material rather than having students cram material into rote short-term memory for mid- and end-of-semester exams. Science is exciting and scientific breakthroughs lead to novel possibilities for the future and new realities. To emphasize the importance of scientific findings, I believe that it is essential to provide the historical perspective, how paradigms change and how new opportunities often develop. In addition, I intend to change things up from class to class by using different instructional methods such as Powerpoint presentations, handwriting of notes, audiovisuals and forming small discussion groups for problem- solving tasks. In addition, the curriculum would be supplemented online with class notes, weekly quizzes and bulletin boards for receiving questions, feedback and the organization of study groups.

Training Laboratory Personnel
I will draw upon my extensive laboratory training, both as a graduate student and post-doctoral fellow, and concentrate my greatest energies on teaching three aims immediately after a student enters my group. The first aim revolves around issues of personal safety and identifying the potential dangers associated with the chemicals and equipment being used. Moreover, The second aim is to teach scientific planning, focusing on selecting appropriate experimental controls and data interpretation. These steps are taken to improve their efficiency by recouping the greatest amount of information from their early experiments. The third aim will involve participation in a weekly laboratory journal club, presenting articles from high-impact journals. I think this aim is especially important as I have found students to often accept a paper’s findings at face value without much critical evaluation of the procedures and interpretations.

The presentation format will include:

  • an introduction addressing the big picture of the field and subsequently, clearly defining the scientific questions being tackled,
  • careful selection of figure data necessary to convey the novel findings of the study and explanation of the methodologies used, and
  • thoughtful discussion of the conclusions including the meanings of the investigation for the field and new questions that the article may have raised.

I think that this type of scientific presentation is key for developing confidence, encouraging “outside of the box” type thinking and critically evaluating the authors’ conclusions. Aside from learning about recent scientific findings and teaching invaluable presentation skills, this exercise will also be important for early education into the preparation and writing of manuscripts. Furthermore, I will encourage a multidisciplinary scientific approach so that students acquire new skills, broaden their research background, form collaborations and ensure their long-term career success. As students mature, they will attend scientific conferences, present their work to larger audiences, receive greater independence and scientific freedom, and participate in grant writing. In conclusion, the development of good mentor-trainee relationships will be one of my highest priorities.